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ABSTRACT 
Cervical Intraepithelial Neoplasia (CIN) or Human Papilloma Virus (HPV) is known as the 
precancerous stages of cervical cancer and may be treated with antineoplastic agents 
Current treatment includes intravenous administration of Gemcitabine and 5-Fluorouracil 
however, these drugs have an undesirable side effect profile. This may be overcome by local 
administration of chemotherapeutic drugs to the site of the cancer. The purpose of this study 
was to design a drug delivery system that can be locally administered to the site of the 
cervical cancer and possess thermosonic properties. Designs of three Thermosonic 
Injectable Organogels (TIO’s) were undertaken using ring opening polymerization (open ring 
reaction) to formulate three different gels to test the response ability of the gels against 
thermal and ultrasound exposure. The times taken for these gels to form were recorded at 
below 15 minutes. All three TIO’s responded differently to thermal and ultrasound stimuli. 
Physical changes in the gels were noted and further studies were undertaken to confirm their 
responsiveness towards the dual-stimuli. All three TIO’s showed a dense microstructure 
containing pores catering for the incorporation of drugs or drug-loaded carriers. Rheological 
studies showed that there was an increase in viscosity of the gels under increasing heat 
even though the response differed between TIO formulations. The gels were non-cytotoxic at 
distinct concentrations ranging between 6.1mg/ml-7.8mg/ml. Solid Lipid Nanospheres 
(SLN’s) were then designed which encapsulated the mode antineoplastic drug 5-
Fluorouracil. The SLN’s were spherical in shape and had an acceptable poly dispersion 
index (PDI) which was below 0.7 after ultrasonication and filtration of prepared samples. The 
SLN’s were then incorporated by direct additition and dispersion into the TIO formulations 
before undertaking the open ring reaction to form Thermosonic Injectable Nano-Organogels 
(TINO’s). The TINO’s were analysed for its swelling and erosive properties. Results showed 
that the TINO’s posesses both swelling and erosive properties. Furthermore, the TINO’s 
underwent dissolution studies that involved thermal and thermal with ultrasound stimuli to 
test the drug release rate and the stimuli responsiveness of the TINO. Results of the SLN’s 
showed a very slow release rate whether exposed to a single (thermal) or both thermal and 
ultrasound stimuli, indicating that the addition of ultrasound stimuli did not alter the drug 
release from the SLN’s. However, the incorporation of the SLN’s into the TIO’s prolonged the 
release rate. Hence increasing the SLN concentration in the TIO’s reduced the response 
towards ultrasound stimuli. Therefore lower ratios of SLN:TIO provided superior 
responsiveness compared to higher concentrations of SLN:TIO. TIO 1 and TINO 2 released 
drug with thermal stimuli and higher drug release occurred with exposure to both thermal 
and ultrasound stimuli. These TINO’s in conjunction with ultrasound responsiveness may be 
used as a potential platform for the delivery of antineoplastics in treating cervical cancer.   
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CHAPTER 1 
OVERVIEW, RATIONALE AND MOTIVATION FOR THE STUDY 
1.1 Introduction 
Cancer was estimated by the World Health Organisation (WHO) to become the leading 
cause of deaths by 2010 (Bharali et al., 2010). Whilst researchers and industry are making 
continuous efforts to overcome cancer, this non-communicable disease resulted in 
8,200,000 deaths worldwide in 2012. Of all of types of cancer, cervical cancer is known to be 
the third most common cause of mortality in women (Gao et al., 2014). It has been strongly 
associated with the Human Papillomavirus and therefore labelled the only cancer that has a 
definite cause (Hu et al., 2013). Preceding cervical cancer, a condition referred to as 
Cervical Intraepithelial Neoplasia (CIN) surfaces. It consists of three grades, namely; CIN I, 
CIN II and CIN III. As the grade increases, the severity of the condition increases which 
ultimately leads to cervical cancer (Garbett et al., 2014). There is a transformation which 
makes diagnosis of precancerous lesions possible. A change in morphology occurs within 
the squamocolumnar junction of the human cervix during puberty thus increasing the 
chances of developing CIN (Herfs et al., 2012).  
 
Modern medicine allows scientists to develop nanomedicines where structures of 
nanoscopic size are used for the diagnosis and treatment of cancer (Kateb et al., 2010). 
Extensive investigation has been undertaken on nanoparticles with the intention to progress 
in diagnostic and therapeutic procedures. Progress has developed with nanoparticles via 
creating novel structural and multi-polymer design. Through this, multifunctional systems can 
be engineered and used for anti-cancer drug delivery (Jia et al., 2013). 
 
Stimuli-responsive materials have shown beneficial results to advance the world of in drug 
delivery science due to their rapid response to environmental physicochemical stimuli such 
as ultrasound or temperature (Zhao et al., 2013). For decades, High Intensity Focused 
Ultrasound (HIFU) therapy attracted the interest of the medical fraternity for cancer therapy 
and is considered favourable over many other cancer therapies such as radiation due to the 
minimal or complete non-invasive process. During this process a rapid increase of 
temperature occurs at the site where the ultrasound is focused. This is an advantageous 
procedure and can be used in combination with drug delivery systems that are responsive to 
heat in a synergistic manner and contribute to site specific targeted drug delivery (Li et al., 
2011). Additionally, ultrasound enhances the delivery of drugs using nanocarriers via 
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sonoporation, which is the formation of temporary pores in the cell membrane induced by 
ultrasound, enabling enhanced intracellular delivery of drugs to viable cells (Pan et al., 
2004). Initially, HIFU was invented with the intention of performing extracorporeal medical 
procedures in tumour treatment. The waves from the ultrasound are able to penetrate 
deeper into the body than light (Li et al., 2010). It was suggested by Burov in 1956 that HIFU 
be used for the treatment of malignant tumours (Dogra et al., 2009). 
 
Anticancer drugs possess a high elimination rate and therefore high doses are required for 
cancer therapy. Furthermore, anticancer drugs are non-specific and results in damage to 
healthy tissue (Bharali et al., 2010). Cancer drugs also have extreme side-effects. 
Furthermore, HPV lesions in particular cause modification in the Human Leukocyte Antigen-
G (HLA-G) expression that leads to inhibition of immune function (Bortolloti et al., 2013).  
 
Therefore, this study explored the design of a novel drug delivery system incorporating Solid 
Lipid Nanospheres into Thermosonic Injectable Organogels (TIO’s) to form Thermosonic 
Injectable Nano-Organogels (TINO’s), which maybe injected at the site of the tumour and 
upon exposure to stimuli, react and release the anti-neoplastic drug. In this work, 5-
Fluorouracil was used as the model drug for potential targeted treatment in cervical cancer. 
Thermosonic is used to describe the thermo-ultrasound dual-responsiveness of the TINO’s 
 
1.2 Rationale and motivation for this study 
The proposed TINO’s were designed to function as a controlled released system; this can 
produce a significant result in controlling the challenge of side-effect profiles faced in cervical 
cancer chemotherapy and contribute to decreasing drug resistance. The advantages of the 
TINO formulation include its ultrasound-responsive capabilities; its efficiently high drug-
encapsulating properties, high cellular uptake, increased permeability and retention 
capabilities via ultrasound application and stimulation. 
 
Thermo-responsive and ultrasound-responsive polymers was used to design the TINO’s that 
are controlled and self-regulated by responding to ultrasound stimulus in order to activate 
drug delivery of treatment. HIFU is considered an efficient and safe method of treatment for 
cancer. As ultrasound energy was focused, it increased heat towards the desired target 
where a TINO containing the chemotherapeutic drug is administered. The TINO will react to 
the heat produced by ultrasound energy at the tumour site. This will result in drug being 
released at the targeted site. Synergistically, sonoporation may enhance the uptake of the 
drug intracellularly into the tumour site. Therefore this formulation is intended to be used with 
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HIFU which is less invasive. Figure 1 provides a schematic the process of how the TINO’s 
were intended to be used.  
 
This novel system is an advancement to current nanotechnology delivery systems with 
multiple advantages as it aims at decreasing invasive procedures and undesirable side 
effects during ultrasound application e.g. HIFU treatment, while synergistically treating 
cervical cancer through localised administration with enhanced permeability for positive 
therapeutic outcomes. 
 
      
           
 
         
Figure 1. Schematic representation of a) TINO units (drug-loaded SLN within the TIO) b) 
TINO injected into cervical cancer tumour site c) ultrasound application targeting the tumour 
site d) TINO responding to ultrasound, causing increased drug release and intracellular 
permeability of the tumour due to an increase in localized heat. 
 
1.3 Aim and objectives  
The aim of this project was to design a novel Thermosonic Injectable Nano-Organogel 
responding to thermal change produced by ultrasound such as HIFU High Intense Focused 
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Ultrasound. This would cause drug to be released in a controlled manner at the tumour site 
in cervical cancer.  The following objectives were fulfilled: 
 
1.  The selection of appropriate stimuli-responsive polymers with properties which responds 
to thermal changes together with ultrasound application through gellation and 
degradation.  
2.  A novel organogel (TIO) was formulated with the stimuli-responsive polymers selected 
using a developed method, such that the TIO forms a dense network from a polymer 
complex that is able to entrap the drug securely and the structure of the TIO was 
determined. 
3. Solid Lipid Nanospheres were formulated as a vehicle for the chemotherapeutic drug and 
was incorporated into the TIO.  
4.  An appropriate anti-neoplastic drug was incorporated into the Solid Lipid Nanospheres. 
The compatibility of the anti-neoplastic drug towards the polymers and the efficacy of the 
drug with regards to cervical pathology were considered. The consistency of the drug 
distributed throughout the TIO was achieved. 
5. The physico-chemical and physicomechanical properties of the TIO were determined 
including; viscosity, swelling, relience. 
6. In vitro studies were performed and the drug release pattern was determined by 
analysing the comparative drug release for thermal as well as thermal and ultrasound 
combined stimuli on the TINO.  
7. Proliferation studies on fibroblasts were undertaken using the organogel. 
 
1.4 Overview of this Dissertation 
1.4.1 Chapter One 
This chapter introduced cervical cancer, its causes and the pathology of how cervical cancer 
develops. It discussed how medical procedures and developing drug delivery has 
successfully assisted with overcoming the progression of cancer. It also outlined the 
rationale and the aim and objectives in this study. 
 
 1.4.2 Chapter Two 
This is a review paper that discussed targeted delivery of chemotherapeutic agents and 
current trends through thermal and ultrasound responsive systems.   
 
 
5 
 
 
1.4.3 Chapter Three 
This chapter is focused on the design of TIO’s using a ring opening polymerization method. 
Characterization of the TIO’s were undertaken and reported.   
1.4.4 Chapter 4 
This chapter discussed the synthesis and characterization of SLN’s and the assembly of the 
SLN’s with the TIO’s. The drug release of the TINO’s was analysed. 
1.4.5 Chapter 5 
This chapter concluded the dissertation with the provision of possibilities and 
reccomendations to improve this study. 
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CHAPTER 2 
A REVIEW OF THERMO- AND ULTRASOUND-RESPONSIVE POLYMERIC SYSTEMS 
FOR TARGETED DELIVERY OF CHEMOTHERAPEUTIC AGENTS 
 
2.1 Introduction 
 
Through the decades of development in cancer treatment, chemotherapy has proven to be 
the world's standard management for most cancer conditions (Deckers & Moonen, 2010). 
Due to the high cost challenges that arise with new therapeutic approaches, the healthcare 
fraternity faces difficulty in achieving significant success rates (Yudina et al. 2012). 
Escalating efforts are being made by pharmaceutical scientists to advance cancer drug 
delivery through nanotechnology and the evolution of polymer sciences of biodegradable 
polymeric nanocarriers. These carriers propose an appropriate approach for transferring 
chemotherapeutic drugs and proteins in a desirably controlled manner to the target site 
(Chen et al. 2014). Two classes of polymers, namely thermal- and ultrasound-responsive 
polymers are in many ways associated with advancing cancer therapy (Bawa et al. 2009). 
They have also proven to be of value in biomedical applications, ranging from tissue 
engineering to drug delivery, including gene therapy (Ward & Georgiou, 2011).  
 
Thermoresponsive polymers feature in most copolymeric drug delivery systems, with well-
known examples including P(N-Isopropyl Acrylamide), Pluronic-F127 and chitosan 
(Cooperstein & Canavan, 2013; Hoare & Kohane, 2008; Li, Lim & Wang, 2008; Qui & Park, 
2012; Ward & Georgiou, 2011; Yannic et al. 2008). In most cases these thermo-responsive 
polymers are used to design hydrogels as 3D networks formed by crosslinking of water-
soluble polymers (Hoare & Kohane, 2008). Thermoresponsive hydrogels have been of much 
interest for decades in the field of drug delivery (Kost & Langer 2012). Their properties 
include phase transitioning, altering drug solubility, and controlling drug release at a desired 
rate (Banerjee, Chaurasia & Ghosh, 2010). Internal stimulation of smart polymer delivery 
systems is ideal for drug delivery from a safety perspective, however careful external control 
of a temperature stimulus is the standard by which thermo-responsive hydrogels respond to 
modulate drug release (Nazar, 2013; Zhu & Torchilin, 2013). An example of employment of 
heat as an external stimulus is Hyperthermia Treatment (HT) where accurate and focused 
heat at temperatures ≥42°C is produced at specific radio frequencies. The induced heat 
alters the morphology of the target tissue which assists in increased blood vessel 
permeability for enhanced drug delivery or ablation of cancerous tissue (Schmaljohann, 
2006).  
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Ultrasound is also applied in advanced medical procedures for tumour therapy through heat 
production. This has proven to be a potently effective and a safe method of tumoural 
ablation, as well as promoting tissue generation (Curley et al. 2014). Ultrasound-responsive 
polymers can be classified into biodegradable (polylactides, polyglycolides) and non-
biodegradable polymers (ethylene vinyl acetate, poly(lactide-co-glycolide). Zhou and co-
workers suggested the forward-thinking approach of nanocarriers in combination with 
ultrasound for diagnostic and/or therapeutic applications (Zhou et al. 2014). 
 
In keeping with the fact that these two advanced classes of polymers are commonly applied 
for chemotherapeutic delivery systems, it is pertinent that a concise review of research in 
this area is assimilated as a foundation of work that has been undertaken, as well as 
highlighting the potential to make advancements in this field. This review provides a concise 
and critical exploration into the subject matter by discussing the advantages and 
shortcomings of thermal- and ultrasound-responsive drug delivery in cancer therapy; in 
addition to the functional properties, phase transitions, as well as underlying scientific 
mechanisms of these delivery systems.  
      
2.2 Advantages and Mechanisms of Cancer Targeting via Thermoresponsive Systems 
There are many other advantages that exist with regard to thermoresponsive polymers from 
their function and design to their application and administration. They are widely used in 
biomedical application in drug delivery and gene therapy and also branches into tissue 
engineering. This smart polymer has the ability to be developed and transformed into 
different formulations in order to carry out their function as intended, these include; micelles, 
hydrogels, particles, films etc (Gandhi et al. 2015). These formulations can be modified by 
adding additional elements such as gold or magnetic material for enhanced performance 
e.g.  good heating properties . External sources of stimulation such as laser power can be 
used to create the desired response i.e. tumour specificity. Cancer is known to increase 
normal body temperature, augmenting the thermal stimulus towards thermo-responsive 
systems (You, Almeda & Auguste, 2010).  
  
P(NIPAM) is amphiphillic with a lower critical solution temperature (LCST) between 30-34°C, 
often used in cancer chemotherapeutics due to its excellent thermoresponsive behaviour . At 
room temperature, the structural network of P(NIPAM) hydogel exists as an aqueous gel 
network. P(NIPAM) hydrogel is generally administered as a depot or an injectable implant 
exposed to body temperature (37°C). At 32°C the hydrophilic fragments of the gel network 
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become hydrophobic due to the presence of the isopropyl group that the polymer contains 
and the gel expels the aqueous content from the network, resulting in polymer-solvent 
interaction (Iyer et al. 2013). These are osmotic mechanisms that are dependent on the 
polymer-polymer affinity, hydrogen ion pressure and the rubber elasticity of individual 
strands of the polymer, resulting in shrinkage of the network until all chains within the matrix 
collapse to form a solidified gel (Kimita, Braithwaite & Luckham, 1999). Once the matrix 
collapses the drug entrapped within the network is released into the tumour tissue (Figure 
2.1). Pluronics also function via this mechanism, being used in long-term anti-cancer therapy 
as demonstrated by Chen and co-workers (2013).   
 
Several amphiphillic block copolymers also exist as aqueous soluble systems in water at low 
temperature and have reversible phase transition properties after sol-gel conversion has 
occurred. This property is known as thermoreversibility, which is composition and 
concentration dependent. Thermogels were produced from poly ethylene glycol 
(PEG)/polyester copolymers via the introduction of hydrophobic blocks onto the copolymer. 
Examples include PLGA, PCL, poly (Ɛ-caprolactone-co-D,L-lactic acid) (Yu et al. 2014). 
There is a fine line between the hydrophilic and hydrophobic ratio composition which falls 
within the viable region to produce a thermoreversible network for cancer therapy application 
(Galaev & Mattiasson, 2007). A PLGA-PEG-PLGA amphiphillic co-polymeric injectable 
thermogel designed by Ci and co-workers loaded with irinotecan, proved to regress colon 
tumours through a sustained release mechanism (Ci et al. 2014). The team demonstrated 
that the drug encapsulated within the thermogel provided improved bioavailability compared 
with drug unaided by the thermogel mechanism (Ci et al. 2014).  
 
 
 
Figure 2.1 Conceptual illustration representing the drug release mechanism of thermo-
responsive systems with an LCST. Adapted from Nakayama et al. (2006). 
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2.3 Advantages and Stimulation Mechanism of Ultrasound-responsive Polymers in 
Cancer Therapy 
Ultrasound promotes a few advantages to drug delivery. As discussed earlier, ultrasound 
offers more than one mechanism of stimulation i.e. through thermal induction, mechanical 
stimulus or gas vapourisation through micro bubbles. These three mechanisms could also 
work as an adjunctive stimulus during drug delivery. Due to these multi-mechanisms and the 
ability to combine them, ultrasound stimulates enhanced permeation of tissue, cell 
membranes and also the blood brain barrier in certain cases ultrasound can act as an 
activator of drugs such as 5-aminoevulinic acid and hematoporphyrin, and can also be used 
for guided therapy (Couture et al. 2014).   
 
Ultrasound is not only known for its safety and inexpensive diagnostic capabilities through 
real-time imaging but also for its therapeutic proficiency through focusing high frequencies of 
ultrasound directed to malignant tumour tissue (Miller et al. 2012). The tissue is ablated 
owing to the thermal, chemical and mechanical effects of HIFU, with minimal side effects. 
Furthermore, ultrasound is a means of promoting healthy tissue regeneration as synergistic 
therapy (Phenix et al. 2014). Recent studies covered in this review highlight that ultrasound 
in cancer therapy is valuable for chemotherapeutic drug delivery and provides the positive 
desired outcomes from decreasing tumour growth and size to eradicating tumours 
completely.Ultrasound plays a role in advancing cancer therapy due to its ability to be easily 
combined in thermo-responsive systems producing a dual functioning for cancer therapy. 
Ultrasound is a stimulus that produces heat, a 'secondary stimulus' by energy vibration 
through acoustic cavitation initiated by acoustic vibrational waves. This heat (UH) calculated 
via a collective time period at 43°C based on the Equation 1:  
 
UH = tR(43-T)                  Equation 2.1 
 
Where t represent the time of the treatment, R is the constant equivalent to 0.25 for 
temperatures 37-43°C and 0.5 for temperatures above 43°C and T is the average 
temperature throughout the treatment; this increases the blood flow in the tumour 
vasculature (Lai, Fite & Ferrara, 2013). These acoustic waves employ a release mechanism 
through cavitation which increases the accumulation of chemotherapeutic drug within the 
site of the tumour. Once the ultrasound activates the polymer, the polymer responds by 
creating air filled microbubbles that eventually burst causing temporary pores in the tissue 
cell membrane at the focal point of application, enhancing tissue permeability which allows 
increased passive targeting into tissue (Legay et al. 2011; Peteu et al. 2010). 
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Figure 2.2  Schematic illustrating low and high power ultrasound assisting in drug delivery 
though microbubbles and cavitation. Adapted from Zhao et al. (2013). 
 
2.4 Properties of Thermoresponsive Polymer Systems: Temperature Ranges at Phase 
Transitions   
The range of LCST’s for thermoresponsive polymers varies significantly. The LCST can be 
modified by blending various thermoresponsive polymers in order to customise the 
physicochemical properties of the system. These include the structural density, surface 
charge, toxicity and transfection efficiency within cancer cells (Cho 2012; Mao et al. 2007). 
Copolymerisation of polymers has also been explored to synthesise thermoresponsive 
polymers with various LCST's. Lai and co-workers have co-polymerised a total of ten 
thermoresponsive polymers with different LCST's to observe how these polymers changed 
the 3D structure of a blood clot (Lai et al. 2014; Yang et al. 2009). Chen and co-workers co-
polymerized poly(glycidyl methacrylate) with poly(NIPAM) as a pendant to  provide a thermo-
responsive gating system for the design of  nanotubes with a  LCST of 32°C. They also 
demonstrated that above the LCST (37°C), the nanotubes remain open sufficiently long 
enough for the activation of proficient drug release. Below the LCST (25°C), the gates were 
in a closing state with no drug release until the activation temperature is once again reached 
(Chen et al. 2014). 
 
Optimal cancer therapy focuses on targeted systems for clinical application.  
Thermoresponsive systems are designed with the LCST responding to the local tumour 
tissue temperature (~40°C) that is required for the release of drugs into the cancer cells 
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(Rezaei et al. 2012). A common challenge with thermoresponsive systems is duration they 
require to undergo phase transition that results in a burst phase of drug release. However, in 
recent developments a study has shown that altering the hydrophilic and hydrophobic 
fragments of the system can enhance the control of drug release by decreasing the thermo-
gelling response time (Banerjee, Chaurasia & Ghosh, 2010; James et al. 2014). 
 
Phase transitions in thermoresponsive systems relate to the solubility properties that 
grounds the common concepts of LCST’s and upper critical solution temperature’s (UCST), 
also known as the cloud point (Abulateefeh et al. 2011; Kikuchi et al. 2014). Below the LCST 
temperature, the structural network of thermoresponsive systems is loosely arranged. As the 
system is exposed to heat, the network becomes denser until it reaches and surpasses the 
LCST with solidification at the site of action e.g. solid tumours or cancerous tissue. This 
subsequently produces an environment for sustained drug delivery, a common goal in 
cancer chemotherapy.  
 
Colloidal-based thermoresponsive drug delivery systems designed for cancer therapy utilise 
polymers with a LCST due to the temperature difference between the body and the exterior 
environment. This facilitates the controlled delivery of the drug to the targeted site. These 
colloid-based thermoresponsive systems encompass liposomes, micelles and nanoparticles. 
Thermoresponsiveness of nanosystems could also occur through thermoreversible swelling 
via cryotherapy or cold shock, which is used in tumour ablation therapy. This allows 
increased porosity of the system and promotes drug release from a state of encapsulation 
(Mura, Nicolas & Couvreur, 2013).   
 
There are very few thermoresponsive polymers that have UCST properties. These polymers 
become soluble at temperatures beyond UCST, whereas LCST polymers become insoluble 
(Mishra et al. 2014). Poly(acrylic acid-co-acrylamide) (P(AAA)) is a thermoresponsive 
polymer that has an UCST due to hydrogen bonding between the acrylic acid and 
acrylamide units (Gandhi et al. 2015). The UCST can vary between 2.5 - 25°C depending on 
the ratio of the two monomers. Phase transitions occur due to hydrogen bonding of 
macromolecules creating intermolecular networks (Yang et al. 2010). Unlike most 
thermoresponsive polymers that work on a negative temperature responsive phase transition 
system, this polymer functions on a positive temperature responsive phase transition 
system. A comparison between normal hydrogel and hydrogel nanoparticles produced from 
P(AAA) was made. The study showed that with an increase in acrylamide, drug entrapment 
of 5-FU was enhanced in both hydrogel and hydrogel nanoparticles but the nanoparticles 
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were more effective in colon cancer due toa higher concentration of 5-FU reaching the colon 
(Ray et al. 2008). Phase transitions of thermoresponsive hydrogels occur through very 
specific mechanisms due to the microscopic nature of the gels. These mechanisms are 
modified in various ways by altering compositions of polymers and by including new 
functional groups into the system.   
 
2.5 Modification of Properties of Thermoresponsive Polymer Systems 
The physical interaction of polymers with its environment and a change in functional group 
chemistry are affected by the modification of the polymers conformational state and its 
solubility during formulation (Yang et al. 2012). The most altered and well known property of 
thermo-responsive polymers is the drastic and reversible changes in solubility (Fuchise, 
2014). The advantages of using thermoresponsive polymers for cancer therapy are 
attributed to the mechanisms of targeted chemotherapy. Zhang and co-workers fabricated 
gold nanorods loaded with doxorubicin for breast cancer which is induced through a thermo-
chemotherapy mechanism activated through a Near InfraRed (NIR) Laser at 760nm, 
500mW, and 16W/cm2 (Zhang et al. 2014). Their studies showed a higher accumulation of 
doxorubicin, in tumours that were heated compared to those that were not exposed to heat 
(Zhang et al. 2014) (Table 2.1).  
 
 
Figure 2.3 Image illustrating a Near InfraRed Laser being applied to the site of delivery and 
the mechanism of action that occurs with heat stimulus. Adapted from Zhang et al. (2014). 
 
Several types of thermoresponsive colloidal carriers were designed for optimum use in 
cancer therapy. These carriers enhance the chemotherapeutic effect by decreasing renal 
clearance due to increased size, which in turn leads to increased circulation time. Increased 
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circulation times are advantageous when the drug is targeted to function at the site of action 
to achieve tumour specificity. These colloidal carriers have the ability to extravasate from the 
tumour vasculature into the tumour tissue, concurrently avoid entering healthy tissue and 
therefore creating a higher quality efficient means of therapy. Furthermore, tumour tissue 
has a slightly higher temperature than normal tissue and therefore these delivery systems 
can be designed to respond to tumour temperature (Abulateefeh et al. 2011).  
 
In many drug delivery developments thermoresponsive polymers are employed as a shell or 
outer layer with the intention of using heat as the drug release stimulus. In a development by 
Purushotum and co-workers, thermoresponsive core-shell magnetic nanoparticles were 
designed for the treatment of multi-modal cancer (Purushotham et al. 2015). These magnetic 
nanoparticles proved to possess good heating properties without the thermoresponsive coat, 
whereas the coated multifuntional system presented with a significant drug accumulation 
and release within the tumour and therefore proved to be a promising system for multi-modal 
cancer therapy (Purushotham et al. 2015) (Table 2.1). 
 
Photothermal Ablation (PTA) of laser origin applied in cancer therapy, coupled with a 
doxorubicin-loaded hollow gold nanoshell system, was used to treat breast cancer. This 
thermally-responsive drug release was initiated by a 3W laser that produced temperatures 
between 54-55°C. However, temperatures between 40-45°C are said to cause extensive 
protein denaturation (Lepock, 2003) (Table 2.1). These temperatures are known to be high 
enough to cause cell death and tumoural ablation (Table 2.1) (Lee et al. 2013). This 
combinatory mechanism has proven to be efficient through histological analysis, tumour 
necrosis was >60% in mice that were treated in conjunction with laser treatment compared 
to mice without laser application (<10%). In evaluating the above systems, the variety of 
stimulating methods requires an understanding of the applicable chemistry that gives rise to 
specific properties through functional structures and trends in polymer sciences. 
 
Thermoresponsive polymers vary in properties according to synthesis of different copolymer 
blends, as well as side-chain or element attachment to existing polymers to produce a new 
polymer or derivative. Modifications of methods of synthesis also alter the structure of 
polymer formation, having an effect on the thermoresponsive ability of the polymer. In a 
study undertaken by Chen and co-workers (2013), di(ethylene glycol) methyl ether 
methacrylate (DEGMA) and oligo ethylene glycol methyl ether acrylate (OEGA) diblock 
copolymers were fabricated with a gold nanoparticle core for cancer therapy (Chen, Xiang & 
Heiden, 2013). It was established that attachment of DEGMA to the gold nanoparticle core 
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had a greater effect in altering the thermoresponsive properties of the system compared to 
OEGA. Steric bulk and polymeric arrangement towards a metal core caused significant 
adjustments to the thermo-responsive properties of polymers. Possessing the gold 
nanoparticle as the core provided value to the systems’ drug release control mechanism by 
converting light waves of 527nm to heat for thermo-responsive drug release into tumour 
tissue and minimal drug diffusion into the blood stream (Chen, Xiang & Heiden, 2013).    
 
Synthesising polymeric derivatives also plays a part in altering the properties of a polymer. 
Kikuchi and co-workers designed four derivatives of a multi-armed star-shaped 
thermoresponsive delivery system from poly[2-(dimethylamino) ethyl methacrylates] (s-
PDMAEMAs) (Mao et al. 2007). It was concluded that in s-PDMAEMAs with a low degree of 
polymerisation a trend of increasing transition temperature was observed (Mao et al. 2007). 
Attaching functionalised groups to a polymer could also change the phase transition 
temperature. Both phenyl and hydroxyl groups were polymerised terminally to P(NIPAM) for 
comparative studies. P(NIPAM) with the phenyl termination had a greater effect on lowering 
the LCST temperature than the P(NIPAM) with hydroxyl termination (Nakayama & Okano, 
2005). Star-shaped amphiphillic co-block polymer micelles were also used in anticancer 
therapy by Rezaei and co-workers (2012). A novelly designed paclitaxel-loaded folate-
decorated system demonstrated an improved efficacy in terms of delivery and specificity. It 
has been suggested by Kikuchi et al that these positive results presented by the micelles 
promote the application for chemotherapeutic drug delivery to achieve high intracellular 
uptake and a significant cytotoxic profile in cancer cells (Rezaeia et al. 2012).  The flexibility 
of being able to modify thermoresponsive drug delivery systems in these numerous ways 
allows for greater advantages of these systems in cancer chemotherapeutics.   
   
2.6 Advancing Functional Trends in Thermoresponsive Polymers 
Structurally, thermoresponsive polymers are known to have methyl, ethyl and propyl groups 
(Qiu & Park, 2012). Amide functional groups and amide-amide interactions tend to produce 
hydrogen bonding and dipole interactions between polymers and allows for thermophilic 
behaviour (Mah & Ghosh, 2013). Well established trends of functionalising 
thermoresponsive polymers is the attachment of antibodies for passively  targeted specific 
delivery which  leads to longer circulation time and accumulation of chemotherapeutic drugs 
in the desired pathological areas (Shao et al. 2011).  Antibody attachment also assists with 
masking the release of drug without any interference by the body's natural defence. This is 
achieved through surface modification of the hydrophobic segment of the carrier system 
(Haidar, 2010).  
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Introducing thermoresponsive systems, such as P(NIPAM), with novel properties has been 
extensively researched in cancer therapy (Kokarderkar et al. 2012). Iron oxide nanoparticles 
with a thermoresponsive copolymer coating were produced with a second set engineered 
with R11 peptides for prostate cancer targeting. The iron oxide nanoparticles are guided to 
the desired site of accumulation via a magnetic field. The R11 conjugated nanoparticles 
proved to have a higher accumulation in the tumour compared to the nanoparticles without 
the R11 conjugated peptides (Wadajkar et al. 2013). 
 
Furthermore, Bao and co-workers developed a multi-functionalised chitosan-grafted 
polyethyleneimine candesartan (CPC) conjugated nano-delivery system for use in the 
treatment of pancreatic cancer (Bao et al. 2014) (Table 2.1). The nanovectors employed 
multiple mechanisms toward chemotherapy by co-delivery of bafilomycin and the wild type-
p53 gene complexed to CPC for the reduction in tumour size. Moreover, the nanovectors 
hinder tumour growth by promoting anti-angiogenesis via reduction of Vascular Endothelial 
Growth Factor (VEGF) secretions due to the candesartan. This synchronised approach of 
hindering tumour growth and reducing tumour size may contribute to elevated success in the 
development of targeted tumour therapy. 
 
Although many researchers have explored chemotherapeutic delivery systems, 
brachytherapy, where radioactive seeds or sources are placed in or near the tumour itself for 
high dose radiation to the tumour and reduced exposure in the surrounding healthy tissues, 
cannot be ruled out from successful delivery in cancer therapy. A thermally-responsive 
elastin-like polypeptide that contains a therapeutic conjugated radionuclide has been 
fabricated by Lui and co-workers (2010) (Table 2.1). The system is suggested to have a 
suitable administration route, a well-controlled delivery mechanism and an increase in 
survival rate. As observed in the above-mentioned systems, heat can be produced and 
transferred in more than one way, significantly generating heat for cancer therapy through 
the exposure of ultrasound. 
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Table 2.1. Thermoresponsive systems in cancer therapy 
Thermoresponsive system Bioactive Cancer type Reference 
Chitosan-g-PEI Bafilomycin 
Candesartan 
Pancreatic Cancer  (Bao et al. 
2014) 
Elastin-Like peptide Radionuclide Advanced stage 
tumoral cancers 
 (Liu, et al. 
2010) 
P(Nipam-co-AA) Doxorubicin Breast Cancer  (Yang et al. 
2012) 
P(Nipam) Doxorubicin Multimodal Cancer  (Purushotham 
et al. 2015) 
PEG-HAuNS Doxorubicin Breast Cancer  (Lepock, 
2003) 
P(Nipam-acrylamide-allylamine)             _ Prostate Cancer  (Lee et al. 
2013) 
P(Nipam-co-N,NDMAM), CHOL-
g-P[Nipam-co-N-(hm)A] 
Indomethacin  
                   
(Chaw et al. 
2004)  
P(Nipam-co-N,NDMAM)-b-PLGA  Doxorubicin Cancer (Liu, Tong & 
Yang, 2005) 
P(Nipam-co-N,NDMAM)-b-PLa Adriamycin Bovine aorta 
endothelial 
(Kohori et al. 
1999) 
P(Nipam-co-AAm) - , Doxorubicin Ovarian Cancer, Colon 
Cancer 
(Meyer, Shin & 
Kong, 1999; 
Strong, 
Dahorte & 
West, 2014) 
P(MOEGA –DMDEA)  Paclitaxel, 
Doxorubicin 
- (Qiao et al. 
2011) 
P(Nipam-co-N,NDMAM)-b-P(LA-
co-CL) 
Doxorubicin - (Nakayama et 
al. 2006) 
P(Nipam-b-PBMA)  Adriamycin - (Chung et al. 
1999) 
Pluronic F127 – chitosan Curcumin Prostate Cancer (Rao et al. 
2004) 
(Fe3O4)-P(NIPAM) Doxorubicin Cancer (Purushotham 
& Ramanujan, 
2010) 
PEG'd Liposimes Doxorubicin Liver Cancer (Yahuafai et al. 
2014) 
DPPC:DPPG:MSPC:mPEG2000-
DSPE (HTLC) 
Cisplatin Cervical Cancer (Dou et al. 
2014) 
DPPC/MSPC/DSPE-PEG2000  Breast Cancer (Tagami et al. 
2012) 
P(NIPAM)-NH2(Amino-
terminated)  
Adriamycin - (Cammas et 
al. 1997) 
Pluronic 127 Paclitaxel, 
Docetaxel 
Breast Cancer, Ovarian 
Cancer 
(Lin et al. 
2014; Yang et 
al. 2009) 
DPPC:DSPC:DPTAP:DSPE:PEG
2000 
Doxorubicin Lung Carcinoma (Dicheva et al. 
2014) 
DPPC:MPPC:DPPE-PEG2000, 
DPPC:HSPC:CHOL:DPPE-
PEG2000 
[Gd(HPDO3A)(
H2O)]+ 
(Doxorubicin 
Squamous Cell 
Carcinoma 
(de Smet et al. 
2010) 
DPPC:CHOL:DSPE-
PEG2000:DSPE-PEG2000-Folate 
Doxorubicin Epidermoid Cancer, 
Cervical Cancer 
(Pradhan et al. 
2010) 
18 
 
 
2.7 Modification of Ultrasound-Responsive System Properties in Cancer Therapy  
Microbubbles have become a common trend in cancer therapy used in conjunction with 
ultrasound therapy. These microbubbles were conventionally used as ultrasound imaging 
diagnostic tools, demonstrating a positive contribution to the advancement in drug delivery 
through overcoming limitations of stimuli responsive systems. Numerous delivery systems, 
as provided in Table 2.3, employ phospholipid microbubbles such as1,2 diestearoyl-sn-
glycerol-3-phosphoethanolamine (DPSE), Perfluorocarbon (PFC),Perfluoropentane 
(PFP),1,2 –dietearoyl-sn-glycerol-3-phosphotidylcholine (DSPC),1,2-dioctadecanoyl-sn-
glycero-3-phospho-(1’rac-glycerol) (DSPG) and many more.   
 
Zhang and co-workers designed methotrexate-loaded nanobubbles composed of a 
copolymer, poly(lactic acid-co- glycolic acid) better known as PLGA. Both individual units, 
i.e. poly(lactic acid) and poly(glycolic acid), are classified as ultrasound-responsive polymers 
(Zhang et al. 2014). This system was designed for targeted therapy in combination with the 
use of tumour ablative therapy through high intense focused ultrasound for placental 
chariocarcinoma. As depicted in Figure 2.4, when the combination therapy of antibody, 
nanobubbles, drug, polymer and HIFU are combined, the proliferation index is decreased 
and the apoptosis index increases significantly (Zhang et al. 2014). It can be deduced that 
adding a nano/microbubble component to the formulation assisted with responsivity to 
ultrasound stimulation.  
 
 
Figure 2.4 Graphs representing the proliferation index and apoptosis index considering 
individual formulatory components and combinations of saline, nanobubbles, drug, 
antibodies and HIFU. Source: Zhang et al. (2014).  
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In delivery systems fabricated from polymers that are not ultrasound-responsive, ultrasound 
delivery is achieved through the addition of agents such as Levovist, an ultrasound contrast 
agent that contains microbubbles or Perfluoropentane (PFP) (Kudo, Okada & Yamamoto, 
2009; Zong et al. 2013). Those microbubbles are then coated with the drug-loaded polymer 
via formation of emulsions to acoustically trigger delivery of chemotherapeutic drugs, for 
example, chlorambucil (Fabiilli et al. 2010). Through a similar mechanism, the drug is 
delivered with efficiency to the intended site. When the ultrasound is transmitted, it interacts 
with the PFP and vaporisation occurs, thus causing the formation of microbubbles. As the 
microbubbles increase in volume and surface area, they facilitate drug release by bursting; 
causing temporary pores within the desired cell layers releasing the drug into the targeted 
cancerous tissue as seen in Figure 2.2 (Cheng et al. 2014).      
 
Yang and co-workers (2014) (table 2.2) designed Poly methylmethacrylate (PMMA)-based 
nanocapsules infused with Perfluorohexane (PFH), a well-known ultrasound contrasting 
agent used to conduct image guided therapy in liver cancer. The nanocapsules were 
uniformly shaped and arranged suggesting easy diffusion into cancer cells, with a high drug-
loading ability of ˃ 90%. Figure 2.5 below illustrates how ultrasound causes drug release 
and sonoporation to assist with drug transfusion into the cells.This may also be seen in 
Figure 2.6 in step [2] and step [3]. 
 
 
 
Figure 2.5 Schematic of sonoporation of the vascular endothelia cells allowing the 
nanocapsules to be in direct contact with the tumour cells which will allow drug into tumour 
cells. Adapted from Yang et al. (2014). 
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Figure 2.6 Schematic illustrating focused ultrasound-mediated drug absorption into cancer 
cells leading to tumour cell death, Adapted from Gourevich et al (2013). 
Gourevich and co-workers (2013) undertook a study considering both the mechanical and 
thermal stimuli emanating from ultrasound and tested the stimuli individually on a 
doxorubicin γ-cyclodextran nanocarrier system that was designed for the treatment of breast 
cancer. Each of these stimuli were compared to a control group and proved to cause an 
increase in encapsulated drug uptake i.e. mechanical, hyperthermia and focused ultrasound 
induced heat respectively. Focused ultrasound (1.35 MHz) in conjunction with MRI guidance 
allowed the drug delivery process to be more efficient, safer and accurate. Introduction of 
SonoVue (sulphur hexafloride) microbubbles permitted a significant increase in intracellular 
doxorubicin uptake (table 2.3) (Gourevich et al. 2013). Ultrasound-responsiveness branches 
throughout a broad spectrum of stimuli allowing many other smart polymer systems to 
respond through heat production and chemical hydrolysis via a pH change. 
 
2.8 Pseudo-Ultrasonic-Responsive Systems in Cancer Chemotherapeutics: Advancing 
Trends in Ultrasonic-Responsive Systems 
Due to the heat ultrasound generates during its application, thermoresponsive systems could 
also be employed in conjunction with ultrasound therapy as a complementary action. As 
highlighted in Table 2.3, Ninomiya and co-workers (2014) designed Thermosensitive 
Liposomes (TSL) from N-isopropyl acrylamide and N-isopropyl methacrylamide whereby, 
upon exposure to locally focused ultrasound (1MHz, 30 s, 0.5W/cm2), heat was produced 
which stimulated the TSL to release doxorubicin for the treatment of breast cancer. 
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Focused ultrasound employed in cancer therapy is useful due to its ability to initiate 
hyperthermia or ablative therapy for tumours. Yang and co-workers [90] designed a 
doxorubicin liposomal delivery system that works in conjunction with pulsed focused 
ultrasound for the treatment of brain tumours (glioblastoma). Results showed that pulsed 
HIFU reduced the tumour growth rate significantly in comparison to chemotherapy alone. 
When the doxorubicin-loaded liposome was introduced unaided by HIFU, it had a longer 
survival rate. When the liposomes were introduced and combined with pulsed HIFU, it 
resulted in an even longer survival rate than the individual approaches (Yang et al. 2012).      
 
Pluronic is a well-known thermoresponsive triblock polymer (PEO-PPO-PEO) composed of 
basic poly(ethylene oxide) and poly(propylene oxide) units. A study was undertaken by 
Husseini & Pitt (2008) using Pluronic P-105 micelles loaded with doxorubicin. An in vitro 
release test was undertaken upon continuous wave and pulsed ultrasound exposure to the 
micelles. Conclusive results proposed that cavitation played a vital role in the disturbance of 
the micelle structure that resulted in drug release of doxorubicin and upon withdrawal of the 
acoustic waves allowed the reformation of micelles and re-encapsulation of drug. 
 
The delivery systems discussed above are stimulated by the 'secondary' stimulus, heat, 
generated via ultrasound, to temperatures high enough to activate drug release from these 
systems. Differentiating between whether the system responds to the thermal or ultrasound 
stimulus is important for future investigations for understanding and improvement of 
ultrasound-responsive drug delivery systems. Due to these thermoresponsive systems 
responding to ultrasound stimuli or being guided by ultrasound, it could be termed 'pseudo-
ultrasonic' responsive.  
 
An interesting study was undertaken by Rapaport and co-workers (2013). Their group had 
synthesised paclitaxel-loaded Perfluorocarbon (PFC) nanodroplets in combination with a 
PEO-co-PLA block copolymer and employed these subsequently to the application of 
focused ultrasound for the treatment of pancreatic cancer. It was suggested that the time 
between injecting the formulation and applying the magnetic resonance imaging guidance 
focused ultrasound (MRgFUS), played a significant role in positive cancer treatment. This 
was due to the time that the formulation required to accumulate in the tumour tissue in order 
for an appropriate concentration of drug to be present for release prior to MRgFUS 
application. If this time is not considered, applying the ultrasound may lead to collateral 
damage to normal tissue (Rapoport et al. 2013). 
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Table 2.2 Polymeric drug delivery systems responsive to ultrasound in cancer therapy 
Ultrasound-responsive 
system 
Bioactive Cancer type Reference 
 PMMA Doxorubicin Liver Cancer (Yang et al. 
(2014) 
γ Cyclodextran Doxorubicin Breast Cancer (Gourevich et 
al. 2013) 
L-α-phosphatidylcholine: 
CHOLl: DSPE-PEG2000 
Doxorubicin Glioblastoma (Yang et al. 
2012) 
PDA:PDLA-PFC Paclitaxel Pancreatic Cancer (Rapoport et 
al. 2013) 
PLGA Methotrexate Placental 
chariocarcinoma 
(Zhang et al. 
(2014) 
APT:P(NIPMAM-co-NIPAM) Doxorubicin Breast Cancer (Ninomiya et 
al. 2014) 
Pluronic Doxorubicin - (Husseini & 
Pitt 2008) 
(DSPE-PEG2000-Biotin) Paclitaxel Breast Cancer (Yan et al. 
2013) 
DSPC:DSPE-PEG2000:DSPG Doxorubicin Brain Cancer (Fan et al. 
2013) 
DPPC:DPSE:PEG2000:Biotin (1,3-bis(2-
chloroethyl)-1-
nitrosourea 
Glioma (Brain/Spinal 
tumor) 
(Fan et al. 
2013) 
CHC:SPIO:BSA (MB) Camptothecan Breast tumour cells (Lui et al. 
2013) 
DPPC-DSPE-PEG-
MALEIMIDE:CHOL 
Doxorubicin Lung Cancer (Geers et al. 
2011) 
PLA Paclitaxel, 
Doxorubicin 
Breast Cancer, Liver 
Cancer 
(Cochran et 
al. 2011; 
Einsbery et al. 
2010) 
DPPC:DPPG:DPPE-PEG 2000 Doxorubicin Cancer (Tinkov et al. 
2010) 
DPPC:DPPA:DPPE-PEG2000 10-
HydroxyCamptotheci
n 
Liver Cancer (Li et al. 2012) 
lyso-lecithin : 
LTSL:ThermoDox® 
Doxorubicin  Squamous  Cell 
Carcinomas (Tumour) 
(Yang et al. 
2012) 
DPPC:MSPC:DSPE-PEG2000 TO-PRO-3 (DNA-
intercalating agent) 
Glioma (Yudina et al. 
2011) 
DSPC: DSPE-PEG(2k)-OMe HLA (Antigen)  (Suzuki et al. 
2009) 
DSPC: DSPE-PEG(2 k)-OMe IL-12 Ovarian Cancer (Suzuki et al. 
2010) 
 
2.9 An Overview of Various Chemotherapeutic Delivery Systems Combining Thermal- 
and Ultrasound-Responsive Polymers 
N,N-Diethylacrylamide (NNDEA) core Pluronic micellular solution (Plurogels®) and regular 
Pluronic P-105 micelles at low concentrations were formulated to release doxorubicin in 
response to low frequency ultrasound for synergistic therapy against leukaemia cells. The 
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Plurogel, being stabilised in comparison to the unstable Pluronic micelles, provided 
enhanced protection of normal cells against the drug through micelle reformation and 
reuptake of drug into the micelle after removal of the ultrasound stimulus, leading to less 
exposure to the drug and lowering the possibility of side effects (Table 2.4) (Pruitt & Pitt 
2002).  
 
PLGA as well as Pluronic proved to be responsive to ultrasound.  According to Liu and co-
workers (2005) [107], thermoresponsive micelles fabricated from the block copolymer, poly 
(N-isopropylacrylamide-co-N, N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) 
contained both thermoresponsive and ultrasound responsive components (Liu, Tong & 
Yang, 2005). In addition to PLGA’s superior biodegradability and drug-loading capacity, an 
increase in drug delivery could be achieved via application of ultrasound.  
 
Polymethacrylate polymers are ionic polymers and are pH-responsive (Chen et al. 2013). 
Research involving application of ultrasound by Wang and co-workers (2009) has been 
undertaken with micelles assembled from a diblock coploymer of thermal- and pH-sensitive 
polymers. Their research demonstrated that applying HIFU to the micelles in an aqueous 
solution produced thermal and mechanical effects that initiated chemical hydrolysis that 
resulted in a decrease in pH and promoted drug release. This delivery system could be 
effective for tumoural delivery due to their lower pH ~5.7 and higher temperatures than 
normal tissue, possibly responding to natural tumour milieu (Gao, Zhang & Sun, 2012). HIFU 
combined with this delivery system would be complementary and may have significant 
potential for tumour therapy.   
 
Stover and co-workers (2008) developed sphingolipid ceramide loaded linear-dendritic 
nanoparticles by grafting P(N-Isopropyl Acrylamide)-P(Lactic Acid),P(NIPAM)-PLA with Poly-
L-lysine-Poly-L-lactide PLLA-PLA for apoptotic action in solid tumours, both of which 
contained PLA, that could be considered an ultrasound component. This system proved to 
be thermoresponsive and provided a long term sustained release ceramide which occurs 
successfully with hyperthermia (Stover et al. 2008).  This system therefore, could be 
triggered via a focused ultrasound stimulus since it is a source of hyperthermia.  
   
A novel intravenous paclitaxel-loaded nano-emulsion was designed by Rapoport and co-
workers (2009), providing pancreatic and ovarian cancer chemotherapy through a 
conversion method technique from nano-emulsion to microbubbles via ultrasonic energy 
ranging between 90KHz-1MHz. Nano-emulsions containing paclitaxel decreased the tumour 
24 
 
 
size significantly whereas the nano-emulsion that did not contain paclitaxel had no effect on 
tumour shrinkage. It was, however, reported that although tumour size reduction did occur, 
tumour resistance was an emerging factor and current research is being undertaken to 
eliminate resistance completely (Rapoport et al. 2009). 
 
Another study undertaken demonstrated that the efficacy of ultrasound was dependent on 
the time allowed for accumulation of the drug at the site of the tumour subsequent to 
administration. This resulted in an increased the uptake of drug into the tumour through 
micelle degradation or tumour perturbation (Gao, Fain & Rapoport 2005). Interestingly, even 
though the system partially comprised of Pluronic-105, ultrasound did not increase 
extravasation of the micelles even 30 minutes after the injection. It was further demonstrated 
that the mixed micelles retained 65% of drug in the core whereas standard Pluronic micelles 
release most of the drug encapsulated. It was indicated that these micelles are effective in 
the early stages of tumour appearance, however once the tumour has metastasized, surgical 
or ablative therapy should be considered before applying this delivery system.    
 
It is reported that nano-sterically stabilised liposomes (nSSL) are known to be very efficient 
in tumours due to their 'leakage' into the tumour (Schroeder et al. 2009).  A study of Cisplatin 
loaded nSSLs in the presence of low focused ultrasound was conducted for chemotherapy in 
colonic cancer in Albino Laboratory-bred (BALB/c) female mice. The cholesterol composition 
in these liposomes decreases the porosity as well as their sensitivity to heat. Using LFUS in 
the presence of drug loaded nSSLs, enhanced the therapeutic effect of delivery systems 
such as these, which do not release drug into the circulation (Gabizon et al. 1994). 
According to Lin and co-workers (2006) cholesterol and PEG-lipid content or lipid packing, 
contributes greatly to ultrasound responsivity in a system. When the temperatures increases, 
it inherently assists with the ultrasound-responsive sensitivity, making it challenging to 
distinguish the quantification of ultrasound- to thermoresponsive sensitivity (Lin & Thomas, 
2004). 
 
A dually-responsive ultrasound-pH responsive polymeric vesicle was synthesised as an 
antineoplastic delivery system. Poly ethylene oxide (PEO) is classified as thermoresponsive 
and poly (2-tetrahydrofuranoloxyethyl methacrylate), a pH-responsive polymer. As previously 
mentioned, ultrasound can activate thermoresponsive systems via heat production and 
stimulate pH-responsive systems via chemical reactions; thus overlapping heat and 
ultrasound. This novel polymeric vesicle proved to have the ability to encapsulate anticancer 
drugs, and release them at a controlled drug release rate, being non-cytotoxic to liver cells 
25 
 
 
below a concentration of 250µg/mL but decreasing liver cell viability (by 25%) above 
500μg/mL. The DOX encapsulated polymers tested against liver cancer cells and proved to 
successfully decrease these cells viability as ascertained via CCK-8 in vitro quantification 
method (Chen & Du, 2013).    
 
Husseini and Pitt (2008) reported on a study undertaken by Howard et al. (2006) based on 
determining the effects of ultrasound on paclitaxel-loaded copolymeric micelles, designed 
from the thermoresponsive PEO, and PLA-tecopherol, where PLA is reported to be 
ultrasound-responsive in nature. When evaluated against breast tumour progression in 
combination with ultrasound (1MHz), not only were normal cells protected from the toxic 
effects of the chemotherapeutic drugs, but the ultrasound assisted in the increasing drug 
uptake in cancer cells ascertained via in vitro studies, and increased tumour regression 
when tested on nude mice (Husseini & Pitt, 2008). 
 
Micelles fabricated from PEO combined with different methacrylates were tested in response 
to HIFU, of which neither of the polymers are ultrasound responsive classified. These 
micelles were encapsulated with nile red (NR) of lipophillic nature and upon exposure to 
HIFU, the micellular structure is disrupted through chemical hydrolysis and causes release of 
NR in a controlled manner (Ayano et al. 2012). Therefore, loading hydrophobic substances 
such as chemotherapeutic drugs in these micelles may be considerable for cancer therapy. 
 
A multifunctional nanoparticle injectable polymeric perfluorocarbon nanoemulsion comprising 
of a PEO-b-PLA diblock copolymer, a thermoresponsive and ultrasound-responsive 
classified combination, were synthesised to release encapsulated doxorubicin in response to 
therapeutic ultrasound to treat breast cancer. In conjunction with diblock delivery system, 
drug-loaded, targeted nanobubbles were included during which the bubbles expand to 
become microbubbles upon heating. Upon rupturing, cavitation occurs and ultimately 
intracellular drug uptake is enhanced; through these mechanisms chemotherapy was 
effectively undertaken (Zeng & Pitt, 2006). Providing an overview of thermoresponsive and 
ultrasound-responsive drug delivery systems assists to create predictable perspectives and 
outlooks. These are vital for discovering innovative approaches to further develop drug 
delivery and research within the field of cancer chemotherapeutics. Table 2.3 provides a 
summary of chemotherapeutic delivery systems with ultrasound and thermoresponsive 
attributes. 
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Table 2.3 Delivery systems incorporating thermal and ultrasound components 
Thermo-
Responsive 
Component 
Ultrasound-Responsive 
Component 
Bioactive Cancer 
type 
References 
N,N-DEAM Pluronic Doxorubicin Leukaemi
a (HL-60) 
(Pruitt & Pitt, 
2002) 
P(Nipam)-co-
N,NDMAM. 
PLGA Doxorubicin Breast 
Cancer 
(Liu, Tong & 
Yang, 2005) 
PEO Poly(thpma) - - (Wang et al. 
2009) 
P(Nipam) -PLA PLLA-PLA Sphingolipid 
ceramide 
Cancer (Stover et al. 
2008) 
PEO PLA Paclitaxel Pancreatic
, ovarian, 
Breast 
cancer 
tumours 
(Rapoport et 
al. 2009) 
PEG2000-
diacylphospholipid 
Pluronic P-105 Doxorubicin Ovarian 
Cancer 
(Gao, Fain & 
Rapoport, 
2005) 
PEG P(βA) Doxorubicin Ovarian 
Cancer 
(Gao, Fain & 
Rapoport, 
2005) 
PE: DSPE CHOL Cisplatin Colon 
Cancer 
(Gabizon et 
al. 1994) 
DPPC  (DPPE-PEG2000) Calcein - (Lin & 
Thomas, 
2004) 
PEO P(2-thfma) Doxorubicin Liver 
Cancer   
(Chen & Du, 
2013) 
PEO PLa-tocopherol Paclitaxel Breast 
Cancer 
(Husseini & 
Pitt, 2008) 
P(Nipam)  PLA - - (Ayano et al. 
2012) 
PEO, P(Nipam) 2-hydroxymethyl 
methacrylate 
Doxorubicin - (Zeng & Pitt, 
2006) 
PEO PIBMA, P(2-THMA) - - (Xuan et al. 
2011) 
PEO PLa, PCL Doxorubicin Breast 
Cancer 
(Gao et al. 
2008) 
P(Nipam-co-PAA) Propylacrylic acid  Doxorubicin Breast 
Cancer 
(Ta et al. 
2014) 
 
2.10 Conclusion and Future Perspective  
Understanding the mechanisms of operation these drug delivery systems is essential for the 
advancement in stimuli-responsive system modification. Thermo-responsive delivery 
systems are widely developed and employed due to their efficient outcomes in drug delivery 
owing to internal and external stimulation i.e. body temperature and laser or ultrasound 
respectively. In terms of external stimulation, drug delivery systems will evolve to an extent 
where most stimuli-responsive systems of various classes of smart polymers could be 
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attuned to ultrasound-mediated delivery, but not necessarily be ultrasound-responsive, as 
ultrasound serves as a source of mechanical impulses that may simulate an environment 
similar to electric impulses, generate a change in heat to stimulate thermo-responsive 
delivery systems, and initiate chemical reactions in certain mediums to cause a pH change 
allowing drug release into the targeted site. Ultrasound, being a well known safe diagnostic 
tool for biomedical applications such as imaging and therapy such as hyperthermia, could be 
used in for many multi-responsive drug delivery systems. The application of ultrasound in 
futuristic approaches to drug delivery would extensively contribute to the enhancement of 
chemotherapeutic drug delivery. In stating that ultrasound induces mechanical effects, future 
research branching into investigating the effect of ultrasound on thixotropic properties of 
drug delivery systems, and responsivity and the efficiency to ultrasound in chemotherapeutic 
delivery systems derived from intelligent materials other than ultrasound-, thermal- and pH-
responsive materials. 
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CHAPTER 3 
FACILE GREEN SYNTHESIS OF THERMOSONIC INJECTABLE ORGANOGELS (TIO’s) 
3.1 Introduction 
 
Stimuli-responsive hydrogels has been an attraction in various biomedical applications 
including tissue engineering, biosensing wound healing and drug delivery (Tong et al. 2015; 
Zhao et al. 2013). Progressive research allowed the development of fourth generation 
biomimetic materials used for stimuli-responsive systems (Knipe & Peppas,  2014) to 
advance into multi-stimuli responsive systems such as dual or tri-responsive to enhance 
mimetic action of the body (Chejaraa et al. 2016; Yan et al. 2014;). By introducing multi-
responsive systems drugs with a high toxic profile such as anticancer drugs can acquire an 
augmented control release of the drug. Understanding that cancerous tissue possesses 
changes in temperature and pH (Zhang, Lin & Gillies, 2010) compared to healthy body 
tissue a dually temp/pH responsive system can be applied to release specifically to those 
conditions. 
 
Recent development of gels includes the incorporation of lipid to synthesize stimuli 
responsive lipogels. This is reported to improve drug encapsulation, extended payload 
retention and modulated drug administration (Lu et al. 2013). Since lipogels have these 
properties, it can be said that they are valuable in anticancer drug delivery and have been 
used to encapsulate antineoplastic agents such as 17 DMAPG, a geldanamycin derivative 
through active encapsulation (Wang et al. 2013). The ring opening method is one of three 
important methods of polymerization in the 21st century and is a well established skill for 
synthetic grafting cyclic monomers e.g. anhydrides and copolymerization of linear polymers, 
most of these reactions are made possible with catalysts under an inert environment with 
controlled temperature (Carlmark, Larsson & Malmstrom, 2012; Lerum, Chen, 2011; Nuyken 
& Pask, 2013) 
 
Several methods used to undertake open ring polymerization is done under inert conditions 
with heat and stirring, these range in periods of hours (Samah & Heard 2013; Silvaa et al. 
2013; Singh & Lyon 2008). Many researchers are moving away from using hazardous and 
toxic material and organic solvents, employing green chemistry techniques towards 
developing improved delivery systems with enhanced biocompatibility. Green chemistry 
follows 12 principles and focuses on replacing any harmful materials or methods with safer 
or alternative options or reducing these toxic materials to a minute concentration of the 
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formulation (Schulte et al. 2013). Furthermore green chemistry is an increasingly pursued 
concept in the pharmaceutical industry due to common errors such as material wastage, this 
includes determining the least quantity of drug that is needed to achieve the therapeutic 
objective working with the most potent compounds of which quantities one will need fewer to 
manufacture the drug that is most efficient and design formulations in a manner that will 
permit increase absorption and decreased excretion into the environment, this specifically 
pertains to chemotherapeutic drugs due to the large magnitude of side effects (Zhang & Cue 
2012). 
 
The use of DMSO is a controversial subject in drug delivery, its claimed to be carcinogenic 
while to researchers, it is known to be a penetration enhancer and is effective when used as 
60% or more in a formulation, other researchers state that it is specifically used as skin 
penetrators in drug delivery (Touito, Williams & Barry 2011; Marren, 2011; Karande & 
Mitragotri 2009). Scheller et al. (2014) reported the use of 5% DMSO injectable 
microemulsion. It is also stated that according to the Australian Code of Practice for the Care 
and Use of Animals for Scientific Purposes a 0,5-5% of DMSO is a permissible concentration 
to use. Injectable in situ systems that employ the polymer precipitation strategy consists of 
water insoluble polymers dissolved in water miscible solvents i.e. N-methyl-2-pyrrolidone or 
DMSO. Injectable gels has captured the interest of many researchers for the past decade 
due to its advantages such as comfortable, effortless and decreased frequency of 
administration, it also promotes healthier patient compliance (Madhu, Shaila & Anwar, 2009).  
 
In our study principles of green chemistry was applied through decreasing and exchanging 
organic solvents, open ring polymerization reaction times are decreased and decrease 
variety of chemicals used to formulate a TIO for delivery of biomedical materials.  
 
3.2 Materials and methods 
 
3.2.1 Materials 
Ethylene Glycol (EG), Ethanol, Dimethyl Sulfoxide (DMSO), N-(Isopropyl Acrylamide) 
NIPAM, Sebacic Acid (SA), 1,3 4-(Carboxyphenoxy) propane (CPP), Sodium Dodecyl 
Sulfate (SDS), Methylene Bis-Acrylamide (MBA) and Ammonium Persulfate (APS). All 
chemicals were purchased from Sigma–Aldrich®Inc. (St. Louis, MO, USA). 
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Preperation of the TIO’s  
3.2.2 N-isopropyl acrylamide and Sebacic Acid – TIO 1 
NIPAM (300mg) was dissolved in 5mL of Ethylene Glycol (EG). Sebacic Acid (SA) 25mg 
solution was separately prepared. The Sebacic Acid solution was added in a drop-wise 
manner to the NIPAM solution to form an emulsion. Sodium Dodecyl Sulfate (7mg) was 
added to the emulsion. Methylene Bis-Acrylamide (135mg) of an appropriate quantity was 
added to the solutions and allowed to dissolve. Within a sealed apparatus under inert and 
heating conditions, the solution (12:1:5:7/50) was stirred with the addition of APS (10%) to 
complete the reaction. Reaction gelling time was recorded. The TIO was then refridgerated 
at 5°C to stabilise. 
3.2.3 N-isopropyl Acrylamide and 1,3 4-(Carboxyphenoxy) propane  - TIO 2 
NIPAM (300mg) was dissolved in 5mL of EG while CPP (25mg) was separately dissolved in 
0.25mL of DMSO under mild heating condiotions. The CPP solution was added to the Nipam 
solution in a drop-wise manner to form a milky suspension. Sodium Dodecyl Sulfate (7mg) 
was added to the emulsion. Methylene Bis-Acrylamide (90mg) was added to the solution 
(12:1:1:3/10:7/50). Under similar conditions as mentioned above, TIO formation was 
achieved. Reaction gelling time was recorded. The TIO was then refridgerated at 5°C to 
stabilise. 
3.2.4 N-isopropyl acrylamide, Sebacic acid and 1,3 4-(Carboxyphenoxy) propane - TIO 3 
NIPAM (300mg) was dissolved in 5mL of EG while SA (25mg) and CPP (25mg) solutions 
were prepared separately under mild heating conditions. The CPP solution was added drop-
wise to the SA solution under mild heating conditions with the resultant of a cloudy emulsion. 
The resultant emulsion was added drop-wise to the Nipam solution.  Sodium Dodecyl Sulfate 
(7mg) was added to the emulsion. Methylene Bis-Acrylamide (90mg) was added to the 
emulsion (12:1:3/10:7/50). TIO formation was achieved through similar conditions previously 
mentioned. Reaction gelling time was recorded. The TIO was then refridgerated at 5°C to 
stabilise.  
3.2.5 Drying Protocol of the Thermosonic Injectable Organogels TIO’s 
All samples were washed and dried using a specific method. The TIO’s were washed in 
ethanol, twice the amount of TIO for 2 hours. Thereafter the washed TIO’s were left to settle 
and separate from the organic solvent. The solvent was decanted and the same amount of 
ethanol was added to the TIO’s and washed for a further 2 hours. After discarding the 
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supernatant, the washed resultant was left in the oven at 60°C until it formed a very thin 
layer of solid gel. The layers of TIO’s were then transferred to a mortar and liquid nitrogen 
was added to the mortar to freeze the samples. During this reaction the TIO’s were crushed 
to a fine powder. The powder was transferred to a petri dish and placed back into the oven 
at 60°C to ensure the powder was free of moisture. The resulting product was then collected 
and ready for characterization.           
3.2.6 Thermo- and Ultrasound Response Analysis 
Images of the TIO’s were captured against a black screen at different assimilated conditions 
to evaluate the efficiency of the dual mechanism. The TIO’s were taken out of the fridge and 
left to stabilise at room temperature, after heating in an oven to 39°C (Tumoural temperate) 
and after exposure to ultrasound stimuli, the trigger release stimulus for the TIO’s 
assimilated by the SCIENTECH ultrasound bath at set conditions temperature (°C) 25˚C, T 
(min) = 5 min Intervals, Power = 005 and the frequency = Lo and the time was recorded. 
3.2.7 Morphology Analysis of the TIO’s 
The morphological structural analyses of the three dried TIO’s were undertaken using the 
scanning electron microscope (FEI PhenomTM, Hillsboro, Oregon, USA). The dried TIO 
samples were mounted on the SEM stubs using double sided adhesive carbon tape. The 
fixed samples were coated with gold for 2 minutes employing a gold sputter-coater (SPI 
Module TM Sputter Coater, SPI Supplies, PA, USA). The images obtained were on a 100 
µm scale to analyse the surface morphology and the physical structure of the three TIO’s. 
Two images of each TIO at different views were obtained.  
3.2.8 Chemical Structure Integrety Analysis of the TIO’s   
Identification of new bonds were established through fourier transform  infrared spectroscopy  
employing the Perkin Elmar Spectrum 2000, Llantrisant , Wales, UK that utilizes a single 
reflection diamond MIRTGS detector (Perkin Elmar Spectrum 100, Lantrisant, Wales, UK) 
fixed with a universal ATR polarization accessory (Perkin Elmar Ltd.,Beaconsfield, UK) 
possessing a resolution of 4cm-1. The parent compounds were scanned to obtain the 
spectrum of each monomer and the complex of every TIO to detect the possible structural 
molecular transitions during the preparation of the combined formulations. The cone probe 
was used for all samples and each sample was set to scan 10 times.The resultant outcome 
was the average of all ten scans in the range of 1800-550cm-1 at a set pressure of 120 psi. 
All three TIO’s were analysed to obtain comparative results in the molecular transitions and 
these were reported. 
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3.2.9 Thermoanalytical Analysis of the TIO’s   
Thermal analysis was carried out using differential scanning calirometery (DSC) with the 
Mettler-Toledo, DSC1 STARe system, Switzerland to obtain the thermal behaviour of all 
monomers and changes in phase transitions and melting points in the TIO complexes. All 
samples were measured at an average weight of 10±1mg in 40-µL aluminium crucible pans 
with a finished pinhole on the crucible lid and underwent thermal analysis of temperatures 
between 20°C-500°C at a rate of 10°C/min under a constant N2 atmosphere. TIO complexes 
were analysed to observe new melting points which occurred that related to the results 
presented by the monomer. 
3.2.10 Phase Identification of the TIO’s  
The solid state of the TIO complexes in powder form and individual polymers were analysed 
through the employment of the Rigaku MiniFlex600 Benchtop X-Ray Diffractometer (Rigaku 
Corporation, Tokyo, Japan) equipped with a 600 W (40 Kv-15mA) X-ray generator, a high 
intensity D/tex ultra high speed 1D detector and a counter monochromator that cuts X-rays 
with the exception of Cu Kα X-rays. The results of all parent monomers and all three TIO’s 
were evaluated for the molecular arrangement of the compounds in terms of crystalline or 
amorphous arrangement. Observations between XRD and DSC results were compared for 
complimentary status of the molecular arrangements. 
3.2.11 Rheological Analysis of the TIO’s  
Rheological studies were performed on all TIO samples. Rheological assessments of the 
TIO’s were undertaken using the Haake Mars (II) Modular Advanced Rheometer System 
using cone plate geometry (C35/1, D =mm, 1° Titan). The TIO’s and a reference were 
prepared for comparison assessments. They were removed from the refrigerator and left to 
stabilize at room temperature. The following tests were performed for each TIO: a) 
Frequency sweeps b) dynamic viscosities at various shear rates and c) temperature ramp 
assessments. Oscillatory frequency sweeps were undertaken from 50 to 0.10 Rad.s-1 at a 
continuous shear stress of 1Pa and a temperature of 25°C for all TIO’s. Temperature ramp 
tests were performed from 20°C to 50°C at a constant frequency of 1 Hz and analysis of the 
graphs were reported.   
3.2.12 Physicomechanical Behaviour of the TIO’s   
The change in physicomechanical behaviour of the TIO’s were evaluated using the Texture 
Analyser (TA.XT plus, Stable Microsystems, Surrey, UK) employing a 50mm circumference 
textural probe whilst increasing temperature from 25°C to 39°C was applied via a heating 
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chamber (Peltier Cabinet). Compression strength (CS), gel resiliance (GR) to evaluate the 
energy of the TIO’s, recognized through elastic deformation and, rigidity gradient (RG) and 
the deformation energy (DE) were investigated under heating conditions to test the 
increasing strength of the TIO’s under thermal stimuli. The parameters were set as follows: 
Pre-test speed=0.20 mm/sec, test speed=0.2mm/sec, post test speed=5mm/sec, target 
mode=distance, distance=8mm, trigger type auto (force), trigger force=100g, break 
mode=off, stop plot at =start position, tare mode=auto, advanced options=on. 
3.2.13 Cell Culture and Fibroblast Proliferation Studies  
A cell proliferation study was undertaken for a period of 5 days. The fibroblast HeLa cell line 
was purchased from Sigma Aldrich. The cells were transferred into a T25 flask containing 
5% FBS media solution that had been pre incubated (CO2 5%, 37°C). The cells were 
washed and nurtured every two days using DPBS and replacement of media. Once the cells 
reached confluency, they were transferred to a T75 flask to culture a sufficient number of 
cells. Once confluency was reached the cells were counted by means of a new bar chamber 
and a microscope. The cell count (CC) was calculated at 1000 cells in 100µL using the 
following equation: 
[The number of cells (in the 4 corner quadrants)/ 4] x Dilution factor (4)          Equation 3.1 
The cell proliferation was performed using an MTT assay Kit purchased from Sigma Aldrich. 
A 96 plate well was used to undertake the proliferation of the cells. In each well plate 100µL 
was instilled and the well plate was incubated for 24 hours. Concentrations of washed TIO to 
media of 10mg/mL, 5mg/mL, 2.5mg/mL and 1.25mg/mL were tested in wells containing 
1000cells/cm2. Once the dilutions were prepared the well-plate was incubated for 5 days. 
The cell proliferation for day 1, day 3 and day 5 were determined using a plate reader and 
bar graphs were plotted to represent the proliferation of fibroblasts. The method was 
adapted from Lin Zhang and co-workers (2014). 
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3.3 Results and Discussion 
 
3.3.1 Assessment of the gelation rate of the TIO’s 
 
Figure 3.1 Bar Graph comparing the gelling time during preparation of TIO 1 TIO 2 and TIO 
3. Standard deviation < 0.75 (N=3) 
3.3.1 Assessment of the Gelation Rate of the TIO’s 
In this study three TIO’s and a reference TIO were prepared and the times taken for these 
TIO’s to form were recorded. The reference TIO reaction was allowed to stir for twelve hours 
in the absence of heat and N2, whereas the other three gels were exposed to both 
conditions. The reference resulted in no TIO formation over a twelve hour period. This 
confirms that without heat and an inert environment the reaction cannot take place, possibly 
due to the inability for the APS to be initiated and the formulation exposed to the external 
environment respectively. Considering the three TIO’s, TIO 1 (12:1:5:7/50) presents with the 
fastest gelation time of 2 minutes and 8 seconds compared to TIO 2 (12:1:3/10:7/50) 3 
minutes and 25 seconds and TIO 3 (12:1:3/10:7/50) 12 minutes and 40 seconds. Kabiri et al. 
(2003) reports that the higher the crosslinker concentration, the shorter the gelation time; 
particularly with MBA. 
 
TIO 2 (12:1:3/10:7/50) had a slightly longer gelation time than TIO 1 (12:1:5:7/50) but shorter 
time than TIO 3 (12:1:1:3/10:7/50).This can be accounted for due to the lower crosslinker 
concentration to TIO 1(12:1:5:7/50) and the presence of SA in TIO 3 (12:1:1:3/10:7/50) 
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respectively. SA also provides gelation properties when reacted with polymers that lack the 
ability to gel on its own such as CPP. TIO 3 (12:1:1:3/10:7/50) presented with the longest 
gelation time compared to TIO 1 (12:1:5:7/50) and TIO 2 (12:1:3/10:7/50) this relates to the 
lower crosslinker and the absence of SA in TIO 3's (12:1:1:3/10:7/50) formulation and may 
also be related to the double concentration of DSMO (Shikanov & Domb, 2005). 
 
3.3.2 Evaluation of the Stimuli-Responsiveness of the TIO’s  
 
Analysing figure 3.2 a) TIO 1 consisting of Nipam and SA, it can be observed that at room 
temperature the TIO tilted at a 135° angle presents a low physical degree of flowability due 
to its high viscosity. Once a) was exposed to a 39°C temperature (Tumoural temperature) 
the viscosity was increased to become a stronger TIO, when rotated to a 270° angle the TIO 
maintains its status by holding its weight against gravity. After confirming that the TIO has 
thermosensitive properties it was placed directly from the oven and placed in the ultrasound 
bath for measured periods with low frequencies at 40°C. TIO 1 took 110 minutes to lose its 
integrity to ultrasound stimuli and it can therefore be deduced that the thermoresponsive 
properties of the TIO are strong as it holds its own weight and ultrasound responsiveness is 
present. This is owing to the formulation as it consists of Nipam and SA with no CPP 
decreasing the ultrasound responsive sensitivity and once responded it moves in bulk.  
 
Assessing figure 3.2 b) TIO 2 under the same conditions as a) the flowability of the TIO is 
increased at room temperature studying the smooth gradient of the TIO tilted at a 135° 
angle. After exposed to tumuoral temperature and rotated to a 270° angle, the TIO maintains 
its status as a stronger TIO holding its weight against gravitational force, demonstrating 
thermoresponsive properties. The sample was directly transferred from the oven to the 
ultrasound bath. Thereafter the application of 15 minutes of ultrasound at a rotation just 
above 180° and the rate of flowability was increased. The bulk flow was not as much as a) 
TIO 1.  
 
Assessment of c) TIO 3, showed a similar behaviour to a) and b) when exposed to heat and 
ultrasound (30 minutes), however physical changes to the TIO state was very minor when 
exposed to the stimuli. After heating, at a 270° rotation there is a slight increase in the 
viscosity of the TIO and presents with a bulk flow above 180° rotation respectively. Even 
though TIO 2 and 3’s responsive times to ultrasound are shorter compared to TIO 1, it can 
be concluded that further studies should be undertaken on all three TIO’s to evaluate the 
efficacy of each TIO’s response to both stimuli.  
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Figure 3.2 Figures illustrating the mechanism cycle of response to thermal and ultrasonic 
stimuli a) TIO 1 b) TIO 2 c) TIO 3.    
                                                  
3.3.3 Evaluation of the TIO’s Morphological Structure 
 
The general morphology of the TIO’s was all very similarly structured in formation. It can be 
observed from the images below that the TIO’s structure contains striations and pores along 
the surfaces. The pores of image 3.3a) are of similar diameter and widely dispersed 
although inconsistently arranged. The pores presented in image 3.3a) illustrates a lower 
quantity and can be related to the increased MBA concentration that possibly decreases 
pore quantity and porosity, this was also reported by Chavda and Patel, 2011. 
Concentrations of MBA were increased from 7.37% to 14.36% resulted in a decrease in 
porosity (Chavada & Patel, 2011). Capturing a magnified view of the gels appearance in 
3.3.b) the detail of the TIO’s formation of its pores and striated appearance can be observed. 
The striated appearance is presented by a bundle of threadlike formations clumping to form 
the TIO and pores are created in the process.   
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The observed distribution of the pores in 3.3.c) complements even and increased loading of 
any substance whether it being the active or the vectors encapsulating the active for 
augmentation of drug release. The increase in pores compared to TIO 1 is due to a lower 
concentration of MBA. The cracks seen in this image and the latter, is caused by the drying 
process of the TIO’s. A pattern that can be observed when analysing 3.3.d); the pores are 
concentrated greatly along the striations as previously noted in the enlarged area of image 
3.3.b) pores are highly visible compared to the smooth surface. 
 
Comparing 3.3.e) with the former image, a similarity of pores along the striations can be 
seen but they prove to be equally dispersed on the smooth surface of the TIO. It can also be 
noted in image 3.3.f) that the smooth surface contains pores although randomly dispersed. 
Although the surface morphology of all 3 TIO’s are similar, the general structure of the gels 
provided by the images below suggests a randomly arranged molecular configuration due to 
the inconsistent forms that are present in the images. Amorphous gel systems are used as a 
strategy to increase the solubility of hydrophobic compounds or drugs to enhance drug 
loading and release by preventing re-crystallisation when exposed to the dissolution 
medium.  
 
 
 
Figure 3.3 SEM Images TIO 1, a) and b), TIO 2 c) and d) and TIO 3 e) and f). Illustrating the 
general surface morphology of the TIO’s.  
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3.3.4 Chemical Structure Identification of the TIO’s   
 
FTIR was undertaken for TIO 1, 2 and 3 and its individual constituents. Studying the graphs 
below, it can be seen how each constituent presents itself in these TIO’s by either forming 
new bands or shifting bands. From the noted bands of the monomers it can be deduced that 
there is the presence of a C=O stretch carbonyl group at 1645cm-1 and following this; the 
most important band is the -NH band at 1546cm-1 which represents the presence of the 
amide in the structure (Thoing et al. 2013; Xue et al. 2014). Another significant band may be 
noted at 1243cm-1 suggesting a -NH amide III band (Dharmesh et al. 2016).  
 
Analyzing CPP structure the most important bands to find are the following, a carbonyl group 
C=O stretching can be seen prominently by wavenumber 1690cm-1 (Jung, Park & Han, 
2010). This illustrates a hydrogen bonded carboxylic acid attached to an aromatic ring. C-O 
stretch can be seen at 1242cm-1, and may represent ether which is present in the structure 
of CPP. The area demarcated 2 expresses newly formed bands, this is due to CPP, TIO 1 
does not contain CPP and will not present with these new bands. Furthermore bands at 
847cm-1 and 770cm-1 accounting for aromatic ring presence in TIO 2 and TIO 3 due to the 
presence of CPP can be noted (Mayet et al. 2014). Studying SA, although not aromatically 
bound, the most prominent band peaks at 1691cm-1 falling within very close proximity of 
CPP's significant band representing a hydrogen - bonded carboxylic acid bonded to a C=C 
depicted by SA's structure. 
 
Having established the main peaks of each monomer, a concise interpretation was made. 
TIO 1, having no CPP does not present with bands that represent aromatic rings as there 
are no aromatic rings in NIPAM nor SA. TIO 2 and 3 contain CPP and therefore present with 
bands that correspond to aromatic bands found in the CPP spectra. The low intensity that 
the band presents is due to the concentration of CPP in the total formulation. Furthermore 
the spectra for TIO 2 and 3 illustrates a new but low intensity band at 1249cm-1 which is not 
present in TIO 1, confirming that this band is caused by crosslinking of the CPP monomers 
with the other monomers. 
  
The greatest changes are the additional bands that are formed in all three TIO’s spectra 
outlined in demarcation 1 between 821 and 1171cm-1. This suggests the formation of new 
bonds in all three TIO’s as these bands do not exist in either of the monomers. The 
formation of a band at 1037cm-1 indicates -CH deformation vibrations and a band presented 
at 1080cm-1, representing a C=O carbonyl functional group bound to an aromatic ring 
structure (Mabrouk et al. 2015). A shift of the prominent band expressed in the NIPAM 
spectra from 1546 to 1643cm-1 in all three synthesised TIO spectra and could be a result of 
C-N stretching related to the degree of crosslinking (Hoosain et al. 2014). In demarcation 2 
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there is a prominent band present in TIO 2 and TIO 3 at 1244cm-1 and is absent in TIO 1. 
Since TIO 1 contains no CPP it can be assume that this C-C stretch bond is formed by the 
addition of CPP. The decrease in the intensity of the peak may be due to the concentration 
ratio within the formulation (Bijukumar et al. 2015).   
 
 
 
Figure 3.4 FTIR Spectra illustrating the chemical transformations of the monomers to the 
TIO formulations  
 
3.3.5 Thermoanalytical Assessment of the TIO’s  
 
Thermal analyses were elucidated by DSC graphs produced by the DSC. All three 
monomers and TIO’s thermograms are presented in figure 3.5. A detailed analysis of the 
thermal behaviour was done on the TIO’s. Each monomer illustrates a relatively sharp 
specific endothermic peak relating to their individual melting point. The melting points of 
NIPAM, CPP and SA are 60-63°C, 310°C and 135°C respectively (Sailakshmi, Mitra & 
Gnanamani, 2013). NIPAM conveys a peak at 64.09°C, CPP at 310.84°C and SA at 
136.34°C. 
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Considering the properties and thermal behaviour of the 3 TIO’s, the glass transition (Tg) 
temperatures of all three TIO’s are 34.81oC, this is the temperature by which an amorphous 
systems changes from the glassy to the rubbery state (Abbas, 2010). The thermal behaviour 
of the TIO’s, presents with higher thermal activity as thermograms depicts additional 
endothermic and exothermic peaks that are broader. This relates to the molecular 
arrangement of the TIO’s. TIO 1 and TIO 3 presents with a broad exothermic peak at 
125.24oC as well as a broad endothermic peak at 181.48oC representing thermal activity in 
line with SA and suggests the decrease in crystalinity by an extensive degree and is not 
seen in TIO 2 as it is absent (Choonara et al. 2015). This endothermic peak represents the 
crystalline melting point of the gels and is more pronounced in these gels containing SA. 
 
NIPAM has the highest concentrated solid monomer in all three formulations, NIPAM 
endothermic peak shifts to a higher temperature of about 184.41 °C, but forms a broader 
peak suggesting a decrease in the crystallinity phase of the TIO from the parent monomer. 
TIO 2 and TIO 3 containing CPP presents with broader endothermic peaks compared to TIO 
1 which depicts a greater intensity peak. This accounts for the presence of CPP in TIO 2 and 
TIO 3.  Amorphous delivery systems possess enhanced molecular mobility and increased 
thermodynamic properties (Tejaa et al. 2013). 
 
The presence of CCP suggests a decrease in the intensity of the shifted NIPAM peak. TIO 1 
containing no CPP, presented with an endothermic peak of greater intensity than TIO 2 and 
TIO 3 that contain CPP. The broad endothermic peak presented by TIO 1 and TIO 3 at 
approximately 125.24°C is due to the SA content in the two formulations of which TIO 2 
does not contain and hence does not convey. It could be said that the presence of SA is 
responsible for the increase in intensity of the NIPAMs’ peak and also a decrease in thermal 
behaviour from approximately 300°C. 
 
Proceeding the crystalline melting peaks , the thermograms depicts crystallisation of TIO 1 
and TIO 3 before the melting points are reached .Endothermic peaks signify that the melting 
points of the gels which are 270.99oC, 278.26oC and 251.73oC which correspond to TIO 1, 
TIO 2 and TIO 3 respectively. Following the melting point in TIO 1 and TIO 2 the 
endothermic peaks present itself at 368.05oC and 358.04oC, at these temperatures the 
process of crosslinking takes place also known as the curing process, the presence of this 
crosslinking peak is dependent on the concentration of the crosslinker (Hoosain et al. 2014). 
 
 
49 
 
 
 
 
Figure 3.5 Thermal behaviour of the TIO formulations and their parent monomers  
 
3.3.6 Physicochemical Integrity of the TIO’s 
 
The key focus of this characterization test was to observe the changes in state between 
crystallinity and amorphous arrangement of molecules from the monomers to the TIO’s. 
Through general overview of the graphs presented in figure 3.6, all three monomers are in 
the crystalline form and all three TIO’s are in amorphous form. NIPAM shows one main peak 
that has intensity of 5103.75 a.u. at 14,23° and less intense peaks at 12.92°,21.58°,22.54° 
with intensities of 439.76°, 866.13° and 439.76° respectively.CPP also has one main 
intensity peak based at 16.85° with an intensity of 945.78 a.u. SA shows 3 major peaks at 
18.95°, 21.23° and 39.58° at intensities of 170.85, 97.22 and 202.87 a.u.   
 
When analysing the gels it can be noted that all three TIO’s have transformed from 
crystalline phase to amorphous phase, they formed a broad peak at an average intensity of 
960.92 a.u.  at 21° from sharp intense crystalline peaks demarcated on the graph. This can 
be due to the physical interaction between the monomer during crosslinking. 
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A correlation between the transformations from the monomer state to the TIO state can be 
observed when comparing the results of the outcomes provided by the DSC and XRD 
graphs. All three monomers give sharp peaks for DSC and XRD and for the TIO’s the peaks 
become broad, the difference is TIO’s obtained greater thermal activity given by the increase 
in the number of peaks due to merging properties of the monomers and the crystalline 
structure of all the monomers become a consistent amorphous gel. 
 
 
 
 
Figure 3.6. X-ray Diffraction depicting the physicomechanical nature of TIO 1, TIO 2, TIO 3 
and the parent monomers of the gel 
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3.3.7 Rheological Evaluation of the TIO’s  
 
 
 
Figure 3.7 Frequency sweep of TIO 1, TIO 2, TIO 3 and a Reference. 
 
A frequency sweep test was conducted for all three TIO’s and a reference formulation. The 
graphs for TIO 1, TIO 2 and TIO 3 conveys that these gels have a greater elastic modulus/ 
storage modulus, depicted by G', than its viscosity modulus/ loss modulus G" whereas the 
reference this behaviour is not present. This suggests that all three TIO's have a strong 
structure. TIO 3 has the highest increase in elastic modulus (G') from 741.23 Pa to 2426.06 
Pa whereas TIO 2 and TIO 1 increase from 62.50 Pa to 455.1 Pa and 451.60 Pa to 847.13 
Pa respectively. From this observation it can be said that TIO 3 has the greatest mechanical 
strength. Considering the linear viscoelastic region (LVR), it can also be noted that TIO 3 
has the largest LVR with a substantially higher G' value of 2426.06 Pa and G'' value of 
1135.86 Pa compared to TIO 2 with a storage modulus G' value of 455.17 Pa and a loss 
modulus G'' value of 245.80 Pa and TIO 1 possess a G' of 847.13 Pa and loss modulus G'' 
value of 235.67 Pa (Bairi et al. 2014). These results can be directly correlated with the 
compression strength outcomes of all three TIO’s confirming the strength of each TIO.      
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Firgure 3.8 Temp ramp rheological characterization for TIO 1, TIO 2, TIO 3 and a Reference   
 
Temp ramp tests between 20°C and 50°C were performed on all three TIO’s and the 
reference formulation in order to observe the thermal gelling behaviour of each TIO. In sol-
gel formulations loss modulus G'' initially dominates storage modulus G', which represents 
the formulation as a liquid state as the temperature increases, a rapid increase in G' occurs 
compared to G'' and results in the intersection of G' and G''. At this point G' supersedes G'' 
and the solutions transforms into a gel (Li et al. 2014). Figure 3.8 depicts G' as initial 
dominance suggesting that the natural state of the formulation is already in a gel state.  In all 
three gels G' has a drastic increase compared to G'' representing a change in gel state to a 
stronger gel confirming successful response to thermal stimuli. It can be noted that TIO 1 
has the most drastic change in storage modulus (G') compared to TIO 2 and TIO 3. 
According to this analysis TIO 1 has the strongest response to thermal stimuli. The reference 
formulation presented with no storage modulus (G') results and therefore no gellation 
occurred during heating of the formulation.   
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Figure 3.9 Graphs illustrating the shear viscosity for TIO 1, TIO 2 and TIO 3. 
 
The shear viscosity results of all three TIO’s and the reference TIO are presented in figure 
3.9. In all three TIO’s it can be observed that with an increase in the shear rate (Ƴ) yield 
there is a decrease in the viscosity of the TIO. This portrays that all three TIO’s have shear 
thinning properties. As the shear rate increases in consistent intervals it can be noted that 
that TIO 3 has an initial increase in viscosity from 776.50 to 1513.87 in the first interval but 
follows the general decrease in viscosity as in TIO 1 and TIO 2. TIO 1 has the highest 
viscosity results at every increase in shear rate compared to TIO 2 and TIO 3 with an initial 
viscosity of 102855.66, 34823.78 and 776.50 respectively. A higher crosslinker 
concentration would result in an increase in hydrogen bonding of the functional groups of the 
monomers and lead to stronger networks of the TIO which could be the basis of higher 
viscosity results as seen in TIO 1.    
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3.3.8 Textural Analysis of the TIO’s 
 
Compression Strength, Deformation Energy and % Resilience on TIO 1, TIO 2 and TIO 3 at 
increasing temperature 25°C- 39°C (tumoural temperature) using a Peliter cabinet heating 
chamber. 
 
 
Figure 3.10 Compressive strength demonstrated by TIO 1, TIO 2 and TIO 3. Standard 
deviation <0.25 (N=3). 
 
The compressive strengths of all three gels were determine to evaluate the maximum force 
that the gels endure before losing the ability of resistance towards compression; also known 
as crush loading (Jaikumar et al. 2015). It can be noted from figure 11, that TIO 1 4Pa and 
TIO 3 4.4 Pa possessing sebacic acid presents with a higher compressive strength than TIO 
2 3.25 Pa. Although TIO 1 contains a higher concentration of crosslinker compared to TIO 2 
and 3; the compressive strength of TIO 1is lower than TIO 3. This suggests that the sebacic 
acid and crosslinker concentration plays a significant role in the resultant compressive 
strength of the gel.         
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Figure 3.11 Deformation energy demonstrated by TIO 1, TIO 2 and TIO 3. Standard 
deviation <0.15 (N=3). 
 
Deformation energy is known as the energy that is absorbed by the gel that would result in 
the deformity of the gels nature (Indermun et al. 2014). The deformation Energy graph 
depicts that the concentration of the materials and crosslinker in the gels are indirectly 
proportional to the deformation energy and to the matrix resilience. 
 
 
 
Figure 3.12 Gel Resilience % given by TIO 1, TIO 2 and TIO 3.Standard deviation <3 (N=3). 
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Textural analytical resilience were undertaken on all three TIO’s to establish the ability for 
them to adapt to the change in stress applied, whereby a gel undergoes elastic deformation 
and energy is released thereafter (Inderman et al. 2014; Mabrouk et al. 2015). The resilience 
of the TIO’s was determined through the ratio percentage that links the area under the curve 
from the peak to the base line (subsequent to the removal of the force) and the area under 
the curve linking the peak to the base line (prior to the removal of the force) from a force-
time profile (Hibbins et al. 2014). It can be deduced from Figure 3.11 that TIO 1 has the 
highest resilience of 51.42%. This is followed by TIO 3 (49.01%) and TIO 2 (5.58%). The 
high resilience of TIO 1 can be accounted for due to the increased concentration of 
crosslinker within the TIO compared to TIO 2 and TIO 3 (Tierneya et al. 2009). The high 
resilience of TIO 3 is fairly similar to TIO 1 and this may be due to the presence of SA that 
possesses gelling properties.  
 
3.3.9 Fibroblasts Cell Proliferation Studies 
 
 
 
 
Figure 3.13 Graph Illustrating the EC 50 of TIO 1 TIO 2 and TIO 3 
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The EC 50 of all three TIO’s were analysed to determine the inhibitory concentration of each. 
Numerous concentrations 10mg/mL, 5mg/mL, 2.5mg/mL and 1.25mg/mL were analysed 
over a period of 24 hours. The inhibitory concentration is the concentration at which 50% of 
cells are surviving. The % cell viability for all four concentrations was calculated. Each TIO 
has four points of reference used to plot a scatter graph to observe the trend in nature as the 
concentration of the TIO decreases. The general trend suggests that there is an indirect 
correlation of the concentration of the TIO to the survival of the cells. A line of best fit was 
inserted to obtain the EC50 of each gel, observations were made and results were noted. In 
Figure 3.12, a line of best fit was used to establish the inhibitory concentration by locating 
the point of intersection whereby 50% viability and the concentration meet on the line. 
 
TIO 1 has the lowest EC50 of 6.1mg/mL, TIO 2 possesses the highest EC50 of 7.8mg/mL and 
TIO 3 possesses an EC50 of 7mg/mL. This proposes that the use of these TIO’s over their 
derived EC50 concentrations would eradicate the cells and therefore it is essential to note 
that at 10mg/mL, all three TIO’s are cytotoxic. Concentrations of 5mg/mL, 2.5mg/mL and 
1.25mg/mL were employed to expand the study to determine the cell proliferation at an 
extended period of time in order to assess the gels biocompatibility at all three 
concentrations. 10mg/mL was not included in cell proliferation studies due to its cytotoxic 
properties. An interesting fact that can be noted is that the gels containing DMSO contains a 
higher EC50 concentration than the TIO containing no DMSO. 
 
 
 
Figure 3.14 Graph illustrating the % cell viability on day 1 for TIO 1 TIO 2 and TIO 3. 
Standard deviation <21 in all cases (N=3).   
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Figure 3.15 Graph illustrating the % cell viability on day 3 for TIO 1 TIO 2 and TIO 
3.Standard deviation <20 in all cases (N=3). 
 
    
 
Figure 3.16 Graph illustrating the % cell viability on day 5 for TIO 1 TIO 2 and TIO 3. 
Standard deviation <20 in all cases (N=3). 
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Cell proliferation studies were undertaken over an interval of 5 days. The cell % viability was 
examined on days 1, 3 and 5. The plate reader was set at 570nm for each read. After each 
read, the average was taken for all samples including the blank sample also known as the 
control. The % cell viability was calculated by dividing the average absorbance of the sample 
by the average absorbance of the control sample multiplied by 100. 
 
% cell viability = Absorbance of sample/Absorbance of control x 100          Equation 3.2 
  
The % cell viability was recorded for each day and bar graphs were constructed to present 
the trends of proliferation at each concentration of each TIO on days 1, 3 and 5. It can be 
noted that the concentration of the TIO has an indirect proportion to the % viability of the 
cells. There is an increase in cell proliferation with progression of time, the formulation forms 
a three-dimensional platform by where the cells can attach and multiply. All % viability 
results presents itself with a % viability 50%≤ and increases to 70% ±1 ≤, this suggests that 
all three TIO’s formulations promote cell proliferation and are not cytotoxic within a 5 day 
interval. The EC50 results can be correlated to the % viability, TIO 2 with the highest EC50 
concentration has the highest % cell viability with the progression of the proliferation study. 
TIO 1 and TIO 3's EC50 concentration can also be correlated to their results of the 
proliferation study.  
 
3.4 Conclusions    
Thermosonic Injectable Organogel’s (TIO’s) was successfully designed via a facile process 
by incorporating green chemistry principals such as decreasing concentration and 
exchanging harmful organic substances to less toxic substances. The length of time taken to 
form the TIO’s was directly related to the concentration of crosslinker and is also noted with 
increasing DMSO concentration. Each TIO had its own degree of responsiveness to heat 
and ultrasound, primarily tested via an oven and ultrasound bath. All three formulations are 
readily in gel state and increase gellation as it is exposed to increased heat. TIO 1 has the 
greatest gelling effect in response to heat in accordance with rheological temp ramp tests as 
compared to TIO 2 and TIO 3. The TIO’ss proved to be amorphously structured through X-
ray diffractive measurements which is augmentative for enhanced drug delivery. 
Furthermore all three TIO’s with a concentration of 5mg/mL presented with proliferative 
properties towards fibroblast cells over a period of 5 days and can be said to be non toxic 
with concentrations of ≥ 5mg/mL.  
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CHAPTER 4 
SYNTHESIS, CHARACTERIZATION AND ASSEMBLY OF SOLID LIPID NANOSPHERES 
INTO THE THERMOSONIC INJECTABLE ORGANOGELS (TINO’s) 
4.1 Introduction 
The establishment of nanotechnology has transformed the depth of medicine and 
participated in the essential revolution of oncology advancement (Coccia & Wang, 2015).  
Branching into drug delivery nanotechnology continues to progress in efficient therapy and 
exist in various structures such as nanoparticles, micelles, liposomes etc (Safari & Zarnegar, 
2014; Yuan et al. 2015). Nanoparticles can constitute biodegradable or non-biodegradable 
polymers. It does not need to be polymer based but requires at least 1 submicronic 
dimension and therefore must be ˂1µm (Safari & Zarnegar, 2014; Brigger, Dubernet & 
Couvreur, 2012). Despite 5-Flourouracil being known as an adjunct drug to cervical cancer 
therapy recent research has shown that this drug applied topically serves as efficient 
medical therapy for women who are diagnosed with cervical intraepithelial neoplasia 2 (CIN 
II) (Mountzious et al. 2013; Rahangdale et al. 2014). Local chemotherapy is known to be 
very effective and decreases the chances of tumour recurrences and may increase the 
extent to which the drug penetrates through the tumour tissue (Wolinsky, Colson & Grinstaff, 
2012).5-Fluorouracil is a broad spectrum antineoplastic agent and has been incorporated 
into lipid nanostructures due to its excellent properties of lipid to enhance drug loading and 
controlled release (Andalib, 2012). 
Solid lipid nanoparticles (SLN's) has reported to have increased in popularity due to its 
capability to site-specific drug delivery and decreased both, short and long term toxicity 
(Kakadia & Conway, 2014). SLN's have proved to be efficient in the prevention of 
chemoresistance, could be employed as a vehicle in chemotherpeutic delivery and has an 
advantage in cancers which are chemotherapy resistant (Kang et al. 2010). SLN's have 
proven dominance over other colloidal systems in many ways as they are capable of surface 
modification and are small in size but have a large surface area (Patel et al. 2014).There are 
two noteworthy advantages that SLN’s offer, one of which is during the process of 
formulating the SLN’s; due to an augmented drug encapsulating capacity, the process of 
drug loading less activity i.e. dispersing the drug within the nanoparticle solution. The other 
advantage surfaces during drug release whereby desirable outcomes of the drug are 
enhanced and this can be accounted for by its manufacturing process (Dolatabadi et al. 
2015). A superior structural stability profile exists in SLN’s owing to arrangement of the 
lipophilic core and the singular phospholipid layer bordering the nanoparticle (Thakor & 
Gambhir, 2013).   
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In most cases the drug release from SLN’s is biphasic which includes an initial burst and 
thereafter a controlled release of drug (Kumar & Sawant, 2013). SLN’s is known to have a 
rapid clearance from the body, incorporating these SLN’s into a vehicle such as a gel to 
sustain the release of nanoparticles for a longer period of time has been proven positive 
(Dorraj & Moghimi, 2015). The structure of the polymer used in the gel determines the 
behaviour of the SLN:gel system and is also worth noting that elastic properties present itself 
with the addition of solid lipid material and that SLN:gel formulations possess a prominent 
prolonged release in comparison to SLN’s alone (Bhaskar et al. 2009).  
Ultrasound is an influential approach in drug delivery through its ability of surmounting the 
physiological challenges faced in effective drug delivery such as high molecular weight, poor 
solubility etc (Patel et al. 2014). Ultrasonic energy is used as therapeutic means within many 
medical conditions including tumoural ablation.  Ultrasound mediated therapy has shown to 
increase the safety and efficacy of chemotherapeutic drug delivery through cavitation and 
drug diffusion into tumoural tissue (Miller et al. 2012; Rapoport et al. 2013). The use of 
ultrasound assists and augments the drug release leading to higher release profiles into the 
desired tissue, promoting focused therapy. This is due to the combination thermal and 
mechanical properties that ultrasound possesses, drug delivery can be achieved without 
microbubbles, this is possible through vapourization of gas-precursors (Couture et al. 2014). 
This paper focuses on a recent method in the formation of Solid Lipid Nanospheres (SLN’s) 
through physical mixing of the formulation that is fed through the nanospray dryer and the 
incorporation of the SLN’s into Thermosonic Injectable Organogels (TIO’s) to form 
Thermosonic Injectable Nano-Organogels (TINO’s) . The physical analysis of SLN’s and the 
SLN:TIO (TINO’s) system were undertaken including drug release profiles of 5-fluorouracil 
from the TINO at different ratios of SLN to TIO formulation.   
4.2 Materials and Methods 
4.2.1 Materials 
Poly-l- Lactic Acid (PLA) , Palmitic Acid (PA), Poly Vinyl Alcohol (PVA), Dichloromethane  
(DCM), Methanol, 5-Fluoro Uracil (5-FU). Sigma–Aldrich®Inc. (St. Louis, MO, USA). 
4.2.2 Preparation of the SLN’s 
1:1 and 2:1 SLN’s with Drug 
Two concentrations of SLN’s PA:PLA were prepared 1:1 and 2:1. PA (25mg) and PLA 
(25mg) were weighed and simultneously dissolved in 10mL of DCM. 5-FU (25mg) was 
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weighed out and dissolved in 2mL of methanol with mild heat. Once the 5-FU was dissolved, 
it was added to the stirring PA:PLA polymer solution. At the same time, 1g of PVA was 
measured and dissolved in 100mL of distilled water with mild heating until completely 
dissolved to form a 1% PVA solution. Once dissolved, the PVA solution was allowed to cool 
down while covered to prevent precipitation. The PA:PLA solution was then added to the 1% 
PVA solution during rapid stirring through a thin stream technique and allowed to stir until 
minimal precipitation was achieved in order to coat these SLN’s. Thereafter the mixture was 
filtered with a 0.8µm pore, 50mm filter paper and collected in a cylinder. The resultant 
solution was then fed through the Nanospray dryer using a 5µm nozzle. The settings of the 
Nanospray dryer were set at the following. Gas flow = 112L/min, Inlet Temperature = 50°C, 
Outlet temperature = 36°C, Head temperature = 63°C, spray = 85%, Pressure = 34mBar and 
the pump = 2. These settings were applied to both concentrations, feeding it through the 
Nanospray dryer resulted in an off white powder which was obtained from the collecting 
chamber of the Nanospray dryer. The powder was collected for both concentrations and 
analytical tests were performed. The best ratio concentration SLN’s where chosen by size, 
morphology and drug entrapment. 
4.2.3 Incorporation of SLN’s into Thermosonic Injectable Organogels (TIO’s) 
The incorporation of the SLN’s was prepared by direct addition of the spheres into the 
formulation. Three TIO formulations were used and three concentrations of SLN’s to TIO; 
1:5, 2:5, 3:5 thus 9 samples of the combined system was prepared. The SLN’s were 
dispersed within the original TIO formulation via mechanical stirring of the mixture until 
dispersion occurred before initiating the open ring reaction of the gel. The mixture was then 
reacted in a sealed vessel under N2 atmosphere kept at a 50°C temperature to form a 
Thermosonic Injectable Nano-Organogel (TINO)   
4.2.4 Probing the Molecular Status of the SLN’s   
Fourier Transform Infrared spectroscopy was undertaken on the individual polymers and the 
newly formed compounds to detect any newly arranged bonds or status changes from the 
individual polymers. This status was established by using the Perkin Elmar Spectrum 2000, 
Llantrisant, Wales, UK fitted with a universal ATR polarization accessory (Perkin Elmar 
Ltd.,Beaconsfield, UK) which possesses a 4cm-1 resolution. The cone shaped probe was 
attached for the reading of all samples. All readings were set at 10 scans to which the 
average was determined and presented and the force gauge was set at a psi of 120. All 
readings were scanned in the range of 4000cm-1 to 600cm-1 and were analysed and 
recorded.  
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4.2.5 Analysis of the Thermal Behaviour of the SLN’s 
The analyses of thermal activity of the SLNs were performed through the employment of the 
Mettler-Toledo, DSC1 STARe system, Switzerland differential scanning calorimeter to 
observe the thermal processes through increasing temperature and attain the activity that 
the SLN’s possess. The individual and compound polymers were weighed into the 
appropriate aluminium crucible pans which were sealed with pinhole crucible lids, 
approximately 10mg and 5mg respectively. The powder filled, sealed crucibles were 
positioned and calibrated individually according to their weights and had undergone a 
temperature rate increase of 10°C/min with a temperature range of 20°C-500°C under a 
constant N2 atmosphere.  Final outcomes of the possessed thermal activity by each powder 
were presented by thermograms produced by the differential scanning calorimeter. The 
alteration in thermal activity points that were notified signified modification of the parent 
polymers.   
4.2.6 Determination of the Molecular Phase Classification of the SLN’s  
The molecular arrangement of the parent polymers and the SLN complex compounds were 
determined using the Rigaku Benchtop X-Ray Diffractometer MiniFlex600 (Rigaku 
Corporation, Tokyo, Japan) incorporated with a high intensity D/tex ultra high speed 1D 
detector ,a 600 W x-ray generator and a counter monochromator which cuts X-rays with the 
exception of Cu Kα X-rays. The XRD graphs of each material generated by the X-Ray 
diffractor was analysed and the phase of each parent polymer and SLN compound complex 
was determined and correlated to the intensity of the peaks presented in the DSC 
thermograms. 
4.2.7 Investigation of the Structural Morphology of the SLN’s  
The structural morphology of the SLN’s were analysed and confirmed using the CARL 
ZEISS SIGMA Field Emmision SEM equipped with oxford x-act EDS detector-England. The 
samples were prepared by attaching a double sided carbon tape to stub holders and lightly 
applying SLN powder samples across the surface area of the free side. These samples were 
then coated with palladium-gold and loaded into the SEM to be analysed.   
4.2.8 Drug Entrapment Efficient Analysis within the SLN’s 
The wavenumber of the drug was set in the UV and a series of dilutions of the drug in PBS 
were prepared. The dilutions were transferred to quarts cuvettes and scanned by the UV 
spectroscopy. A calibration curve was constructed from the UV results obtained from the UV. 
Drug loaded spheres 1:1 and 2:1 was dissolved in methanol with heat and scanned at 5-
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FU's wavenumber and the UV results were recorded. The drug entrapment was calculated 
from the UV results that were obtained.   
4.2.9 Determination of the Size and the Zeta Potential of the SLN’s 
The size of the spheres were analysed using the Zeta Sizer Nano-2s, nanoseries, Malvern 
instruments equipped with a MPT-2 multipurpose tirtrater Malvern Innstruments, This system 
works via dynamic light scattering to determine the size of submicron particles between 0.3 -
10 microns with a sensitivity of 0.1mg/mL. A small amount of approximately 2mg was diluted 
in 5mL of distilled water and ultrasonicated with the ultrasonicator Vibracell for 30 seconds to 
disperse the spheres in the water. The resultant dispersion for each sample was then filtered 
into plastic disposable cuvettes which were then inserted to analyse the size of the sphere 
and give a PDI for the spheres. On average 30 scans were taken before the graphs were 
produced. Samples from the stock dilutions used for zeta sizing were used for zeta potential 
which was loaded carefully into a folded capillary cell by means of a syringe. The air bubbles 
were removed from the folded capillary cell which contained electrodes that allow the 
measurement for zeta potential.        
4.2.10 Evaluation of Erosive and Swelling Dynamics of the SLN’s Incorporated into the 
Thermosonic Injectable Organogel (TINO’s) 
Degradation trials were undertaken with the TINO’s. A total of 12 samples were prepared 
and its initial weights were recorded. The samples were suspended in acetate buffer pH 4.3 
BP 100mL jars and placed in a shaker bath at 50 rpm at 37°C. The weights of these 
samples were recorded at day 1, day 3 and day 7. At each recording the additional residue 
was cleared off the sample before it was weighed. Graphs were constructed according to the 
results to understand the swelling and erosive behaviour. 
4.2.11 Drug release studies from the SLN’s and the TINO’s 
A total of 20 samples two groups of 10 were prepared for the dissolution. The first group was 
thermal tested. The second group was thermal and ultrasound exposed. Each group 
contained the 9 samples with TINO’s and a control consisting of the SLN’s only. The 
samples were sealed in dialysis tubing and suspended in acetate phosphate buffer solution 
(100mL jars) and placed in the shaker bath at 25 rpm, 37°C. At each interval, a withdrawal of 
5 mL of acetate buffer saline from each jar sample. The second group of samples were 
exposed to ultrasound before the sample was withdrawn. The withdrawn sample was 
replenished with fresh acetate buffer saline. The samples were scanned through the UV and 
the UV results were used to calculate the drug release at each interval for both groups. Drug 
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release profiles were constructed from the results calculated and the pattern of drug release 
were studied.          
4.3 Results and Disscussion 
 
4.3.1 Assessment of SLN’s Molecular Status  
 
Figure 4.1 Graph illustrating the surface molecular status of 1:1 PA:PLA plain and 1:1 
PA:PLA drug encapsulated  
Infra-red spectroscopy was undertaken for the pure materials and the SLN; plain and 
encapsulated with drug (5-Fluorouracil) to determine the molecular status of the SLN’s. 
Analysing Figure 4.1, palmitic acid (PA) contains C-H stretch bands that occur between 
2937cm-1 and 2940cm-1 (Garland et al. 2005), furthermore a prominent band at 1695cm-1 
COOH confirming the presence of  the carboxylic acid functional group in PA. Poly-l-lactic 
acid (PLA) comprises of various prominent peaks, one of which 1 peak is very decisive 
1752cm-1 C=O carbonyl group that represents the strong ester backbone of PLA (Xu et al. 
2011), other peaks 1085cm-1 and 1182cm-1 also suggests C-O ester groups. Poly vinyl 
alcohol was used to coat the SLN’s, hence a higher concentration of PVA was used in 
formulating the SLN’s. Analysing the IR spectra for PVA in Figure (4.1and 4.2), a broad band 
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can be noted between 3027-3614cm-1 which proposes hydrogen bonded alcohols (OH). A 
C-H stretch band can be noted at 2942cm-1 and further down the spectrum a strong carbonyl 
band presents itself as it peaks at 1729cm-1. Additionally, a small intensity peak at 1376cm-1 
and a larger, more visible band at 840cm-1 can be observed these bands are reported to be 
C-H wagging and C-H rocking bands respectively (Ahad, 2012). 
 
Figure 4.2 Graph illustrating the surface molecular status of 2:1 PA:PLA (plain) and 2:1 
PA:PLA (drug encapsulated)  
A broad band can be seen between 2750cm-1 and 3250cm-1, this confirms the presence of 
the amine as stretching bands around 3000-3500cm-1 are usually attributed to the NH 
stretching vibrations in the spectrum of 5-Fluorouracil. A band at 1250cm-1 indicates a CF 
stretch band that represents a carbon-flouride bond in 5-FU (Olukman, Sanli & Solak, 2012). 
When analysing the IR spectra of the SLN’s in both Figure 1. and 2. , it can be noted that the 
spectrum is almost identical to that of PVA with the exception of the intensity of the peaks, 
substantiating that PVA coated the SLN’s.  
4.3.2 Analysis of the Thermal bevaiour of the SLN’s  
Differential scanning calirometery was performed on the pure polymers and the SLN’s, the 
thermal behaviour of all of these compounds was determined by the thermographs produced 
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by the DSC instrument. In figure 4.3 PA has a melting point of 68.59˚C falling within a similar 
range reported by Latibari et al. (2014) thereafter no thermal activity can be seen until a 
visible exothermic peak is produced this could represent the oxidative degradation. When 
observing PLA, the first activity can be noted at approximately 184.89˚C and soon after at 
190.25˚C which signifies the glass transition of PLA. At 358.86˚C a broad exothermic peak 
which could possibly represent the melting point of PLA and that PLA is amorphous in nature 
can be observed. PVA undergoes glass transition at 57.04˚C and crystallization at 276.32˚C 
before presenting a broad exothermic peak signifying its melting point at 323.39˚C. 
 
Figure 4.3 Graph illustrating the thermal behaviour for 1:1 PA:PLA (plain) and 1:1 PA:PLA 
(drug encapsulated).  
When analysing 5-Fluorouracil, a sharp peak can be noted at 278.09˚C which is the melting 
point for 5-Fluorouracil (Olukman et al. 2012). At approximately 349.14˚C 5-FU undergoes a 
process known as cold crystallization. When analysing the SLN’s a very similar thermal 
activity to plain PVA can be seen, this could be due to the higher concentration that is used 
to coat the SLN’s. The thermograms representing the SLN’s show a lower melting point than 
pure PVA. With regards to the thermal activitiesof the SLN’s, it can be noted that the drug 
encapsulated formulation has a slightly lower melting point and less intensepeak than the 
formulation with no drug. Furthermore, the encapsulated SLN’s expresses thermal activity at 
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472.45˚C and 479.64˚C for 1:1 PA:PLA (25% 5-FU) and 2:1 PA:PLA (33.3% 5-FU) 
respecitvley.    
 
Figure 4.4 Graph illustrating the thermal behaviour for 2:1 PA:PLA (plain) and 2:1 PA:PLA 
(drug encapsulated). 
4.3.3 Classification of the Molecular Phase of the SLN’s  
The molecular phase classification was determined by the graphs provided by the XRD 
instrument and the molecular phase of each polymer was resolved by the results obtained 
and confirmed by comparing the results of the XRD to that of the DSC. Studying the XRD 
graphs from Figure 4.5 and 4.6, PA has three peaks, the first peak occurs at 2.42˚C with an 
intensity of 3809.80a.u. The second peak presents a sharp more intense peak of 
9824.67a.u. at 21.74˚ and another occurs at 24.62˚ with an intensity of 1997.55a.u, with the 
position reported by Latibari et al. (2014). These sharp intense peaks suggest that PA has a 
crystalline lattice structure, when comparing the peaks of PA for the DSC and XRD, a 
correlation of the sharp intense peaks can be noted. PLA possesses a broad peak that 
occurs at 16.99˚with a low intensity of 56.06a.u proposing an amorphous molecular structure 
that can be confirmed by the broad peak present in the DSC thermogram of PLA. A broad 
peak occurs at 19˚ with a low intensity of 45.63a.u. for PVA which indicates that PVA an 
amorphous molecular arrangement and be confirmed by the presence of the broad peak in 
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the thermogram of PVA (Manjunath et al. 2015). Evaluating the XRD graph for 5-Fluorouracil  
a very sharp intense peak of 1086.79a.u. at 28˚ is observed, indicating the crystallinity of the 
drug and can also be confirmed by the sharp intense peaks of the thermogarm of 5-
Fluorouracil (Nair, Jaqadeeshan & Kumar, 2011).          
 
Figure 4.5 Molecular phase classification of 1:1 PA:PLA (plain) and 1:1 PA:PLA (drug 
encapsulated). 
An interesting observation can be noted when analysing the XRD graphs for the SLN 
formulations. As seen in Figure 5. there is a broad intense peak of 5562.86a.u. at 35.63˚. for 
the plain SLN’s and an intensity peak of 5493.78a.u. at 35.29˚, furthermore sharp peaks are 
present 69.36˚ and 81.73˚ which indicates that this formulation could be semi crystalline. In 
Figure 6. It can be noted that the SLN’s XRD graphs presents with a broad band at a low 
intensity of 61.35a.u at 17.67˚ and 58.89a.u at 18.35˚ for the encapsulated SLN’s and the 
plain SLN’s respectively. The broad band confirms the amorphous nature for the SLN’s of 
this ratio.   
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Figure 4.6 Molecular phase classification of 2:1 PA:PLA (plain) and 2:1 PA:PLA (drug 
encapsulated). 
4.3.4 Elucidation of the Structural Morphology of the SLN’s  
The morphology, shape and the size range of the particles were determined by the CARL 
ZEISS SIGMA Field Emmision SEM equipped with oxford x-act EDS detector-England. The 
images in Figure 4.7, depicts the two formulations i.e. 1:1PA:PLA and 2:1PA:PLA with and 
without drug loading. Analysing the shape of the particles it can be confirmed that these are 
spherical in shape and by a greater percentage nanoscale spheres. The morphology of the 
spheres can be described as smooth surfaced spheres which possess contours. The 
scanning electron microscope used to capture these images, was used to demarcate (Da x) 
and measure (nm) spherical dimensions. In Figure 4.7a) two SLN’s can be seen 
Da1=279.2nm and Da2=509.1nm among others, from these it can be seen that there is 
more than one size range. With an increase in surfactant such as tween or span the particle 
size can be decreased and controlled (Shi et al. 2011). In comparison to a) containing drug, 
it can be noted in image b) that smaller particles are present b) Da2=181.6nm. The 
increased sized spheres could be due to the encapsulation of drug. Abbaspour et al. (2013) 
reports that particle size increases when ionic complexed chemotherapeutic drugs are 
encapsulated in the SLN’s and the amount of polymer. When analysing image c) a clear 
difference in the size range can be seen in comparison to a), SLN’s measured possess sizes 
of Da1=666.3nm and Da2=450.7nm. This may indicate an increase in polymer concentration 
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promotes an increase in the size of the SLN’s formed. The average sizes of the SLN’s 
annotated and visible in image d) i.e. Da1=450.9nm and Da2=545.3nm depicts smaller size 
SLN’s in relation to the visible size range seen in image c). 
   
 
 
Figure 4.7 Scanning electron microscope images for a) 1:1 PA:PLA (drug encapsulated), b) 
1:1 PA:PLA (plain), c) 2:1 PA:PLA (drug encapsulated), d) 2:1 PA:PLA (plain). 
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4.3.5 Drug Loading and Encapsulated Efficiency within the SLN’s  
 
Figure 4.8 A calibration curve for 5-FU in methanol. 
The percentage drug loading (DL) for each formulation was calculated with the following 
equation (Maji & Dey, 2014): 
% DL = Weight of the drug in the formulation/Weight of total formulation x 100   
         Equation 4.1 
The drug loading of the two formulations were determined and the % drug load for 1:1 
PA:PLA and 2:1 PA:PLA were 33% and 25% respectively. The drug entrapment efficiency of 
1:1 PA:PLA  and 2:1 PA:PLA  was calculated after dissolving 10mg of each formulation by 
mechanical stirring at rapid speed in methanol under heat (±40˚C). The concentrations of the 
two formulations were 17.49mg and 8.53mg.The following equation was used to calculate 
the encapsulated drug (ED) efficiency (Awotwe-Otoo et al, 2012): 
% ED = Actual drug loaded/Theoretical drug Loaded x100                       Equation 4.2 
Once dissolved, the samples were transferred to a cuvette for UV spectroscopy. The 
calibration curve above was used to obtain the drug entrapment for these two formulations. 
The drug efficiencies of 1:1 PA:PLA and 2:1 PA:PLA is 58.29% and 34.11% respectively.   
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4.3.6 Determination of the Size and Zeta Potential of the SLN’s 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9 Graphs depicting zeta size and zeta potential for 1:1 PA:PLA (plain). 
Zeta sizing was undertaken to determine the size of the SLN’s that are present in the 
different ratio formulations. The size range, Poly-dispersed index (PDI) and the average size 
of the SLN’s present are reported. The PDI gives the size ranges of the SLN’s that are 
present within a formulation, the greater the index the broader size distribution and a PDI 
below 0.7 suggests stability and possess an acceptable size distribution (Sharma et al. 
2014; Abdellatif & Abou-Taleb, 2016).  Figure 4.9 illustrates the percentage of SLN’s that fall 
within a size range. The first peak occurs at 11.72d.nm (size) and has an intensity of 58.1% 
and the second peak, an intensity of 41.9% with a size of 167.4d.nm. The 1:1 PA:PLA has a 
PDI of 0.541 . The highest quantity of SLN’s occurs in the first peak. The zeta potential for 
this formulation reads at -23.2mV indicating that the SLN’s possess fair stability. 
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Figure 4.10 Graphs depicting zeta size and zeta potential for 1:1 PA:PLA (drug 
encapsulated). 
The drug loaded SLN’s showed a greater size range than the plain SLN’s, this could be due 
to the encapsulated drug. Three peaks are presented in Figure 4.10. The first peak occurs at 
11.99d.nm with an intensity of 60.9%, with the following peak at 155d.nm with an intensity of 
36%. Peak three occurs at 5233d.nm with an intensity of 3.1%.The PDI of the 1:1 PA:PLA is 
0.151 indicating a low size distribution of SLN’s. The zeta potential reading in Figure 10. is -
24.6mV indicating fair stability of the nanoparticles. According to Honary & Zahir (2013), 
positively charged chitosan-modified-paclitaxil-PLGA nanoparticles (C-NP’s) promotes an 
electrostatic interaction with cancerous cells due to a negatively charged surface area of 
tumour tissue, hence a greater accumulation of C-NP’s at the tumour site for passive 
intracellular uptake. However it was reported by Grainger et al. (2010) that anionic 
(negatively charged) nanoparticles may be ideal for cancerous tissue as they move rapidly 
through the interstitium due to repulsive forces and settles between the matrix of the cell 
walls. Additionally, pulsed ultrasound may enhance the penetration process.   
 
 
80 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.11 Graphs depicting zeta size and zeta potential for 2:1 PA:PLA (plain). 
In Figure 4.11,  two size ranges of SLN’s exists. The first peak occurs at 12.92d.nm with an 
intensity of 55% and the second peak occurs at 169.9d.nm with an intensity of 45%. The 
SLN’s have an average size of 19.60d.nm with a PDI of 0.597. This suggests that the higher 
the polymer concentration, the bigger the size particles as this can be seen when comparing 
the two concentrations of SLN formulations. Zeta potentials greater than ± 30mV are known 
to retain good stability properties and zeta potentials approaching ±60mV is considered to 
have outstanding stability (Lopez-Garcia & Ganem-Rondero, 2015). It can be noted that the 
zeta potential for 2:1 PA:PLA (plain) is -26.2mV and therefore could be described as 
reasonably stable.    
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Figure 4.12 Graphs depicting zeta size and zeta potential for 2:1 PA:PLA (drug 
encapsulated). 
In Figure 4.12, it can be noted that as with 1:1 PA:PLA (33.3% 5-FU) loaded, 2:1 PA:PLA 
(25% 5-FU) presents with three peaks and the ranges are higher than 1:1 PA:PLA  loaded 
SLN’s. This could be due to the higher concentration of the polymer in these SLN’s. In the 
above figure, the first peak arises at 16d.nm with an intensity of 62.6%. The second peak 
occurs at 153.8d.nm with an intensity of 29.4% and the third peak occurs at 472d.nm. The 
PDI is 0.307 that suggests the ideal size distributions for colloidal systems with a zeta 
potential of -25.2mV. Even though SLN’s experience challenges with stability, improvements 
can be made via the addition of an appropriate surfactant or stabilizer to the formulation 
(Khadka et al. 2014; Narala & Veerabrahma, 2013). 
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4.3.7 Evaluation of the Erosive and Swelling Dynamics of the TINO’s. 
 
 
Figure 4.13 Degradation and swelling profile for TIO 1, SLN: TINO 1 (1:5), (2:5) and 
(3:5).Standard deviation <131 in all cases (N=3). 
Through analysis of Figure 4.13, on day 1 of the degradation study, an increase of weight 
was observed suggesting that TIO 1 is swelling. TINO 1 (2:5) and TINO 1 (3:5) continues to 
increase until day 3, TINO 1 (2:5) reaches a maximum weight of 2565.69mg and TINO 1 
(3:5) reaches a maximum of 2189.50mg, thereafter a decrease in weight is noticeable and a 
further decrease is observed. This proposes degradation of the system. Analysing TIO 1 and 
TINO 1 (1:5), a peak in their weight can be noted, this could be due to water absorption 
between day 1 and day 3, slight degradation can be observed. Between Day 3 and day 7 a 
slight increase in weight can be noticed. Degradation by day 7 reveals that the weight of the 
TIO and TINO’ does not reach its initial mass and can be correlating with the drug release 
profiles. On day 7, TINO 1 (1:5) released the highest concentration (46.8%) of drug and is 
closer to its initial weight faster than the other TINO’s containing 5-FU loaded SLN’s whereas 
TINO 1 (2:5) and TINO 1 (3:5) show a lower drug release profile, (23.8%) and (21.8%) 
respectively.  This suggests a slower degradation rate than TINO 1 (1:5). Figure 4.13 
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indicates that with a higher concentration of SLN’s in this TIO, the swellability of the TINO 
increases. 
 
Figure 4.14 Degradation and swelling profile for TIO 2, SLN: TINO 2 (1:5), (2:5) and 
(3:5).Standard deviation <124 in all cases (N=3). 
When loading the SLN’s in TIO 2 (TINO 2), degradation study patterns differed to those of  
TINO 1. In Figure 15, it can be noted that with an increase of SLN to TIO ratio, a significant 
weight increase of TIO 2 and TINO 2 samples after the first day of the study. Furthermore 
the rate of swelling of the TIO and TINO’s on the first day also depicts an increase in weight 
which is proportional to SLN to TIO ratio. Subsequently to day three a decrease in the weight 
of TIO 2 and TINO 2 samples can be obsereved; the general pattern of activity for TINO 2 
proposes degradation of the samples. TINO 2 (1:5) possesses the lowest weight of 
1918.02mg, TINO 2 (2:5) has a final weight of 2159.27mg and TINO 2 (3:5) has a final 
weight of 2417.29mg. This again suggests that the higher the ratio of SLNs to TIO 
undergoes slower degradation. These degradation results can be correlated to the drug 
release profiles for TINO 2 (1:5), (2:5) and (3:5) which is 67.30%, 43.5% and 41.76% 
respectively on day seven.    
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Figure 4.15 Degradation and swelling profile for TIO 3, SLN: TINO 3 (1:5), (2:5) and 
(3:5).Standard deviation <111 in all cases (N=3). 
The degradation study of TINO 3 conforms to a similar pattern as TINO 1 with regard to 
degradation rate of the TINO’s i.e. the degradation TINO 3 (2:5) has the slowest degradation 
with TINO 3 (1:5) and TINO 3 (3:5) following subsequently. This can be noted with TINO 1’s 
degradation profile. It can be observed, as seen in the two previous degradation figures, 
there is a substantial increase in the weight of all TIO three samples on the first day. 
Thereafter a decrease in weight following an increase can be observed. The pattern of the 
TINO’s suggests an oscillating action between degradation and swelling. However, TIO 3, 
illustrates no oscillation but rather an increase upto day three, followed by a decrease in 
weight. This suggests a prolonged degradation with incorporation of SLN’s (Dorraj & 
Moghimi, 2015). Furthermore, a higher concentration of incorporated SLN’s in the TIO seem 
to decrease the swelling ability of this TIO this could be due to the SLN’s occupying spaces 
within the gels network that fluid would in a plain gel. 
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4.3.8 Drug Release Studies from the SLN’s and theTINO’s 
 
Figure 4.16 Drug release profiles for 1:5 SLN: TIO ratio for TINO 1, TINO 2 and TINO 3. (T= 
Thermal ; TU = Thermal + Ultrasound). Standard deviation < 2.5 in all cases (N=3). 
The general behaviour of all three drug release profiles shows an initial burst of drug on the 
first day and an overall sustained release for the next 14 days. In the drug release profile 
above, The SLN’s presents with the lowest drug release profile in comparison to the SLN’s 
incorporated into the TIO and shows no difference in the drug release when comparing the 
SLN’S exposed to thermal stimulation and the SLN’S exposed to a combination of thermal 
and ultrasound stimulation. This could be due to the gelation phenomenon discussed by 
Yadav et al.(2013), when the SLN’s disperse they undergo rapid crystallization. This may 
have been the reason for the drug profile that is presented (Yadav et al. 2013). Incorporating 
the SLN’s into the TIO increased the % release profiles therefore overcoming the problem of 
SLN gelation. In Figure 4.16, TINO 1 and TINO 2 respond to single and combined stimuli, 
and the TINO’s exposed to the combined stimuli proves to have a release profile higher than 
that of the TINO’s exposed to the single stimuli. TINO 3’s behaviour contradicts the 
behaviour of TINO 1 and TINO 2. TINO 3 exposed to the combined stimuli, responds a lot 
less than the TINO 3 exposed to the single stimuli. It is worth mentioning that TINO 3 
exposed to the single stimuli has the highest drug release and the TINO 3 exposed to the 
combined stimuli has the lowest release of the TINO formulations. From Figure 4.16, it can 
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be concluded that incorporating the SLN’S into the TIO formulation assisted with the 
promotion of drug release.       
 
Figure 4.17 Drug release profiles for 2:5 SLN: TIO ratio for TINO 1, TINO 2 and TINO 3. 
Standard deviation < 2.5 in all cases (N=3). 
In the graph above, it can be noted that the SLN’S presents with the same behaviour as the 
figure before and all dissolution samples has an initial burst on the first day, thereafter has a 
steady drug release up to day 15. When analysing all the groups of TINO’s it can be seen 
that all TINO samples release in a similar manner with regards to the groups of stimuli i.e. 
the TINO’s exposed to the combined stimuli release was higher than that of the single 
stimuli. It can be noted that TINO 1 has the lowest release in a 15 day period suggesting that 
it has the highest sustained release profile of all three TINO’s, with a drug release of 44.29% 
for the thermal stimuli and a drug release of 67.13% for TINO 1 with the combined stimuli. 
TINO 2 has a drug release profile of 74.38% and 92.54% for a single and combined stimulus 
at day 15.  In this ratio of SLN:TIO; TINO 3 supersedes the drug release of TINO 1 and 
TINO 2 releasing 75.16% with thermal stimuli and 96.43% with combined stimuli by the 15th 
day. When comparing the overall drug release of Figure 4.16. Figure 4.17 shows a more 
sustained release with most formulations, this suggests that with an increase of SLN loading 
a greater sustained release is achieved.     
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Figure 4.18 Drug release profiles for 3:5 SLN: TIO ratio for TINO 1, TINO 2 and TINO 3. 
Standard deviation < 2.5 in all cases (N=3). 
Observations of drug release patterns in the above Figure 4.18 can be very closely 
correlated to that of Figure 4.16, the SLN samples release 45.32% of the drug by day 15 as 
in the 2 previous figures. TINO 1 and TINO 2 demonstrates the behaviour desired while 
TINO 3 demonstrates an adverse behaviour as the TINO 3 under thermal (single) stimulation 
presents with a 20.38% higher difference by day 15 as compared to the TINO 3 under 
thermal and ultrasound (combined) stimuli. These release patterns can be seen in the above 
Figure. TINO 1 illustrates a vast difference between the single (40.66%) and combined 
(61.35%) stimuli of approximately 20% difference by day 15 whereas TINO 2 demonstrates 
a 2.27% difference between the single (70.67%) and dually (72.4%) stimulated TINO. It can 
be noted that the % drug release of Figure 4.18 decreased significantly in comparison to 
Figure 4.16 and Figure 4.17. It can be seen that the TINO release curves move towards the 
SLN release curves. This observation substantiates the suggestion made with regard to 
increasing the ratio of SLN’s to TIO formulation. Another observation is that the TINO 
release profiles progresses to a steady linear state release rate as the SLN concentration in 
the formulation increases. 
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4.4 Conclusions 
TINO’s were designed with the intention of in-situ application to the cervix as a potential 
treatment for cervical cancer to which would be augmented through ultrasound application 
as adjunctive therapy with increased drug release to the site. Solid Lipid Nanospheres were 
successfully designed with encapsulated 5-FU. Drug encapsulation increased the size of the 
SLN’s but showed a fair stability and good size distribution. Drug release profiles were 
undertaken for the SLN’s alone and for the TINO’s. The drug release profiles for the SLN’s 
displayed a prolonged release profile but when combined into a TIO it showed an easier 
controlled drug release with the concentration increase of SLN’s in the system. TINO 1 and 
TINO 2 presented with desired results for drug release when comparing the single stimulus 
to the added ultrasound as this is better for local treatment in cancerous tissue.  
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CHAPTER 5 
CONCLUSIONS AND RECOMMENDATIONS 
5.1 Conclusions 
Cervical cancer is rated one of the most prominent and lethal cancers among women and is 
strongly attributed to HPV. Precancerous stages of cervical cancer (CIN I, II, III) are an 
important part of early diagnosis. There are many types of HPV viruses and a great number 
of these are due to sexual contact and therefore has recently been affecting the younger 
population, males and females. If not treated, HPV may progress to CIN eventually leading 
to cervical cancer. HPV vaccines are available as a preventative measure but not every 
individal has the means of acquiring the vaccine due to factors such as social issuesand the 
cost of living, thus alternative approaches are essential. 
The continuous expansion of drug delivery has opened doors of opportunities for 
enhancement of diagnosing and treating procedures, including the augmentation of medical 
procedures such as HIFU application for tumoural ablation. Stimuli-responsive delivery 
systems are being developed everyday and are moving toward nanotechnological designed 
systems for advanced and synergistic treatment in medical conditions including cancer. 
Extensive research has been done on thermoresponsive and ultrasound-responsive delivery 
systems. These two responses complement each other in the presence of ultrasound owing 
to frequencies and heat that is produced by the ultrasound.Many polymers that do not 
respond to ultrasound may be modified in formulation delivery systems to become 
ultrasound responsive. Ultrasound has shown to alter pH in some cases and may be used in 
a variety of modified stimuli-responsive systems in the future. These systems can be termed 
as being ‘Pseudo-ultrasonic’ responsive. 
Combinations of thermoresponsive and ultrasound responsive polymers were employed to 
formulate organogels with a minute concentration of DMSO and additional solvents that are 
less toxic, to determine the responsive properties of the gel. The TIO’s presented with 
different degrees of responses to heat and ultrasound stimuli. However, TIO 3 shows 
minimal physical changes under stimuli response. This dual response system combining 
antineoplactic, heat and ultrasound should synergistically increase the overall therapeutic 
outcome for a patient. The Images of the gels show that they have a very dense network but 
also accommodate for loading of other substances that is; drugs or carriers of bioactives 
such as SLN’s.The SLN’s will prevent unnecessary leakage of the drug to reduce the side 
effects associated with the chemotherapeutic agents. The amorphous nature of the TIO’s 
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adds an advantage towards delivery of drugs and has been proven non-cytotoxic below 
5mg/mL. 
It has been previously established in clinical trials that 5-fluourouracil is efficient in treating 
cervical cancer intravaginally. The SLN’s have proven by a large scale to fall within the nano 
rage through SEM and Zeta sizing and possess reasonable drug entrapment. An increased 
polymer concentration during formulation leads to an increase in size of the SLN’s. The 
TINO’s showed both swelling and erosive properties during degradation studies. The drug 
release profiles for the SLN alone showed a greater sustained release whereas the SLN 
incorporated into the TIO allows for a higher concentration of drug release. TINO 1 and 
TINO 2 provides the desired response for drug release i.e. TINO’s exposed to ultrasound as 
well as thermal stimuli depict greater drug release profiles in comparison to thermal stimuli 
alone. However, TIO 3 did not provide the same response. It can be concluded that TINO 1 
and TINO 2 in conjunction with ultrasound application are potential delivery systems that 
may be further investigated for cervical cancer. 
 
5.2 Recommendations 
 
a) The TIO’s properties could be optimized to improve its injectability and responsiveness to 
body temperature and HIFU via polymer proportion. 
b) The SLN’s maybe optimised to increase the concentration of the 5-FU for maximum 
entrapment. 
c) The TINO delivery system could be optimised with the proportions of SLN:TIO for 
adequate drug delivery. 
d) The TINO’s may undergo animal studies to determine the optimised quantity that would 
deliver the desired outcome.    
e) It may be studied in the management of Human PapillomaVirus (HPV) by decreasing the 
size of the lesion gradually in combination with ultrasound such as HIFU and ultimately 
ablation of the lesion.    
f) It may be studied in the treatment of Cervical Intraepithelial Neoplasia or cervical 
dysplasia by ultrasound application targeting the mutated tissue solely, leaving healthy 
tissue unharmed and increase repairing time. 
g) It could be studied for management of cervical cancer through preventing the 
progression of the staging and grading of the lesion. 
h) It could be studied as treatment of cervical polyps by decreasing the size of the polyps 
until they completely regress in order for healing to commence. 
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Delivery of Chemotherapeutic Agents 
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Abstract 
There has been an exponential increase in research into the development of thermal and 
ultrasound-activated delivery systems for cancer therapy. The majority of researchers 
employ polymer technology that responds to environmental stimuli some of which are 
physiologically induced such as temperature, pH, as well as electrical impulses, which are 
considered as internal stimuli. External stimuli include ultrasound, light, laser and magnetic 
induction. Biodegradable polymers have interesting properties that have proven to be 
thermo-responsive or ultrasound-responsive that can complement cancer therapy through 
sonoporation and hyperthermia by means of High Intensity Focused Ultrasound (HIFU). 
Thermo-responsive and other stimuli-responsive polymers have been used in drug delivery 
systems, activated via ultrasound stimulation. polyethylene oxide/polypropylene oxide 
coblock or triblock polymers and Poly methacrylate(PMA) are thermal- and pH-responsive 
polymers, respectively but have proven to have successful activity and contribution in 
chemotherapy when exposed to ultrasound stimulation. This review focused on collating 
thermal and ultrasound-responsive delivery systems, and combined thermo-ultrasonic 
responsive systems, and elaborating the advantages, as well as shortcomings, of these 
systems in cancer chemotherapy. The mechanisms of these systems are explicated through 
their physical alteration when exposed to the corresponding stimuli. The properties they 
posses and the modifications that enhance the mechanism of chemotherapeutic drug 
delivery from systems are discussed and the concept of pseudo-ultrasound responsive 
systems was introduced.     
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Abstract 
The purpose of this study was to design TIO’s moving towards thermal and ultrasonic 
stimuli.  The TIO’s were non-cytotoxic and biocompatible, with properties of gellation in 
response to tumoral temperature as well as being responsive to ultrasound stimuli. These 
TIO‘s were formulated through a simplistic open ring polymerization process integrating 
green chemistry principals. Fourier Transformed Infrared Spectroscopy (FTIR), Differential 
Scanning Calirometery (DSC),X-Ray Diffraction (XRD), Rheological tests, Scanning Electron 
Microscopy (SEM), Textural analysis and cell proliferation studies were performed on the 
TIO’s in order to obtain the results. Open ring polymerization was achieved in ˂15 minutes. 
SEM images convey the density and microscopic structures seen within the TIO’s such as 
striations and pores which permits facilitated storage for drug loading. New bands are 
observed at 770.9cm-1, 1037cm-1 and 1080cm-1 that represent the presence of aromatic 
rings, -CH deformation vibrations and C-O carbonyl groups attached to an aromatic ring. 
Gels showed an amorphous nature by representation of shallow broad peaks from the sharp 
concise peaks given by the parent monomers. Rheological temp ramp tests depicts the 
storage modulus G' to be higher than loss modulus G'' where G' increases at a faster rate 
than G'' when heat is applied. The compressive strength of the gels was recorded at 4Pa, 
3.25Pa and 4.4Pa. TIO 1, TIO 2 and TIO 3 formulations are non-cytotoxic when used at 
concentrations of 6mg/mL, 7.8mg/mL and 7mg/mL respectively and promote cell 
proliferation within a 5 day period. The design of TIO’s was successfully formulated to 
respond to thermal and ultrasound stimuli.   
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Abstract 
The objective of this study was to design Solid Lipid Nanospheres (SLN’s) with a Poly Vinyl 
Alcohol coat, which serves as a carrier of 5-Fluorouracil and load. These SLN’s were added 
to a TIO’s to form TINO’s with thermosonic properties and releases a higher dose of drug on 
ultrasound stimulus command. FTIR, DSC, XRD, zeta sizing, zeta potential and SEM were 
carried out for the SLN’s while degradation and dissolution studies were undertaken on the 
combined system. FTIR for the SLN’s presented with a broad band between 3027-3614cm-1 
and prominent bands at 2942cm-1 and 1729cm-1. Furthermore, the addition of 5-FU in the 
formulation increases the intensity of the bands. The thermal activity of the SLN’s show a 
slightly lower melting point than PVA (323.29°C) and the drug loaded SLN’s formulations 
show thermal activity that may represent degradation of the SLN’s. The XRD results for the 
SLN’s convey that 1:1 PA: PLA is semi crystalline as it presents with a broad peak at an 
average intensity of 5528.32a.u. at approximately 35.5° while 2:1 convey an amorphous 
nature of the SLN’s. SEM images depicts that with an increase in polymer concentration and 
addition of 5-FU, the size of the particles increase. The zeta potential of the SLN’s are 
between -23.2 and -26.2mV however the PDI of the SLN’s are all below 0.6 and therefore 
can be said to possess a fair to good stability with an accepted size distribution. The 
degradation profiles show that the combined system undergoes swelling and degradation 
and loading of SLN’s into the TIO’s may prolong degradation of the TINO. Drug release 
profiles depict that TINO’s assist with drug release from the SLN and with higher 
concentrations of SLN’s the release profiles are more sustained.  
 
